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The advent of high throughput next generation sequencing (NGS) has accelerated the pace of discovery
of disease-associated genetic variants and genomewide proﬁling of expressed sequences and epigenetic
marks, thereby permitting systems-based analyses of ocular development and disease. Rapid evolution
of NGS and associated methodologies presents signiﬁcant challenges in acquisition, management, and
analysis of large data sets and for extracting biologically or clinically relevant information. Here we
illustrate the basic design of commonly used NGS-based methods, speciﬁcally whole exome sequencing,
transcriptome, and epigenome proﬁling, and provide recommendations for data analyses. We brieﬂy
discuss systems biology approaches for integrating multiple data sets to elucidate gene regulatory or
disease networks. While we provide examples from the retina, the NGS guidelines reviewed here are
applicable to other tissues/cell types as well.
Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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Technological advances in genomics and genetics, accelerated
exponentially by the Human Genome Project (HGP), have begun to
transform most disciplines in biology and medicine. Systems
biology and personalized medicine are no longer beyond reach.
Whole genome sequencing (WGS) is not limited to a chosen few,
and Precision Medicine Initiative has emerged as the approach of
the 21st century for prevention and treatment of human disease
(www.nih.gov/precision-medicine-initiative-cohort-program).
Even evolution and anthropology have embraced the power of
genomic technology. The pace of discovery since the middle of the
last century is astonishing; it was less than 40 years ago when
chain-terminating inhibitors were used for efﬁcient and accurate
sequencing of DNA (Sanger et al., 1977b), putting us on the current
path in genetics and genomics (Fig. 1A). The following decades
demonstrated remarkable technological and conceptual progress in
human genemapping and gene discovery, leading eventually to the
HGP and the ﬁrst draft of 3 billion letters of human genome (Lander
et al., 2001; Venter et al., 2001). The HGP represented amilestone in
biomedicine as it enabled the identiﬁcation of putative genetic
defects by comparing a disease sample with a standard reference
genome. Soon thereafter, HapMap (hapmap.ncbi.nlm.nih.gov) and
the 1000 Genomes Project (www.1000genomes.org) produced
extensive catalogs of human genetic variations (Genomes Project
et al., 2015; International HapMap et al., 2010), making it possibleFig. 1. Timeline of human genetics and genomic technologies. NGS based applications have
DNA molecule until today, substantial scientiﬁc and technical advancements in human ge
published a decade after the launch of human genome project. B. Cumulative number of b
database. We believe the number of scientiﬁc reports based on NGS technologies will conti
variations is more employed than expression and genome binding proﬁling in vision researc
the eye ﬁeld within two years. PCR, polymerase chain reaction; RP, retinitis pigmentosa; HGP
degeneration; GWAS, genomewide association study.to investigate even complex phenotypes andmultifactorial diseases
using genomewide association studies (GWAS).
First massively parallel sequencing approach was reported by
Sydney Brenner’s group and utilized microbeads for producing
gene expression proﬁles from yeast and a human cell line (Brenner
et al., 2000). More widely used next generation sequencing (NGS)
methods have fueled a revolution in biomedical sciences by
addressing the need to generate inexpensive, reproducible, and
high throughput nucleic acid sequence data (Bentley et al., 2008;
Johnson et al., 2007; Margulies et al., 2005b; Mortazavi et al.,
2008; Nagalakshmi et al., 2008; Shendure et al., 2005; Sultan
et al., 2008). NGS has opened opportunities and challenges of
“big data science” to biologists and clinicians for genomewide
evaluation of genetic variations, expression of distinct RNA species,
and epigenetic changes associated with development, aging, and
disease (Marx, 2013) (Fig. 1B and C). “Omics” is now a widely used
term for describing high throughput cataloging and/or analysis of
cellular molecules. We are moving forward to identify all functional
genomic elements (ENCODE Project) (Consortium, 2011; Kellis
et al., 2014) and understanding the role of non-coding variants in
tissue-speciﬁc contexts (GTEx Project) (Consortium, 2015; Gibson,
2015). A massive surge in genomic, transcriptomic, and epi-
genomic data has led to systems level approaches for quantitative
analysis of the dynamic interplay of molecules within a speciﬁc
cell/tissue. NGS-based approaches have also quickly gained broad
applicability in medicine; from genetic diagnosis and diseasebeen utilized widely in vision and other biomedical research. A. From the discovery of
netics and eye ﬁeld are presented in a chronological order. The ﬁrst NGS report was
iomedical research papers based on NGS technologies from 2008 to 2015 in PubMed
nue to increase as NGS becomes more available and affordable. C. Proﬁling of genomic
h studies. As of December 2015, the total number of NGS based studies have doubled in
, human genome project; NGS, next generation sequencing; AMD, age-related macular
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this review, we will discuss basic concepts in NGS technology and
expand on the Illumina platform that is widely used by genomic
biologists.
Retinal degenerative diseases (RDDs) have been early targets of
genetic and genomic advances. The X-linked retinitis pigmentosa
locus, RP2, was the second gene mapped by polymorphic DNA
markers (Bhattacharya et al., 1984), and rhodopsin was the ﬁrst
gene associated with visual dysfunction (Dryja et al., 1990; Farrar
et al., 1991) when positional cloning was still in infancy (see
Fig. 1A). Since then, signiﬁcant progress has been made in deﬁning
the genetic architecture of ocular diseases (Swaroop and Sieving,
2013), speciﬁcally in RDDs with 240 genes identiﬁed as of January
2016 (sph.uth.edu/retnet). Equally signiﬁcant was the pioneering
discovery of Complement Factor H (CFH) variants that are strongly
associated with age-related macular degeneration (AMD) (Klein
et al., 2005), a common multifactorial blinding disease, which
greatly beneﬁtted from the advances in HGP, genomic technologies,
and genomewide association studies (Swaroop et al., 2009). NGS-
based methodologies, and in particular whole exome sequencing
(WES), are now becoming routine in identifying causal variants
associated with Mendelian diseases. The exponential increase in
discovery of rare variants by NGS has provided enhanced impetus
for causal gene discovery in complex diseases. We discuss these
approaches and discoveries in Section 3.
Each of us carries millions of genetic variations that deﬁne our
unique identity (Genomes Project et al., 2015). While a majority of
these variations do not seem to have an obvious pathological
impact, some are associated with human traits or clinically iden-
tiﬁable diseases. Despite the remarkable advancements in discov-
ering disease-associated or causal variants (mutations), molecular
mechanisms and cellular pathways that underlie the pathophysi-
ology have not been adequately delineated in most cases, in part
because of our incomplete understanding of “normal” biological
function. Furthermore, signaling and gene regulatory networks that
control fundamental biological processes, including organogenesis
and aging, are poorly understood in mammals, especially in the
context of the nervous system. NGS-based transcriptome analysis
(RNA-seq) (discussed in Section 4) allows proﬁling of global pat-
terns of expression of distinct RNA species (including mRNA,
miRNA, lncRNA, and tRNA) that perform unique functions within a
given cell/tissue during development or disease pathogenesis.
Temporal transcriptome proﬁling of “normal” and “mutant” retina
can help deﬁne how genetic changes lead to cellular dysfunction
and elucidate gene networks associated with homeostasis and
disease. Recent successes in generating expression proﬁles from
single retinal cell types (Kim et al., 2016) (Siegert et al., 2012) or
even from single cells (Macosko et al., 2015) are providing novel
molecular insights into cell fate determination and disease mech-
anisms. Epigenetic changes are another major factor in inﬂuencing
physiology and biological pathways. NGS can be used to evaluate
changes in histone modiﬁcation (by chromatin immunoprecipita-
tion followed by NGS, ChIP-seq) or chromatin structure (DNase I or
Tn5 accessibility proﬁling, termed DNase-seq or ATAC-seq respec-
tively). Application of NGS in epigenetic proﬁling is discussed in
Section 5. Additionally, ChIP-seq can be utilized to identify targets
of DNA-binding proteins or transcriptional regulators, which
constitute essential components of gene regulatory networks
(GRNs) as demonstrated for Neural Retina Leucine Zipper (NRL) or
Cone-Rod Homeobox (CRX) in the context of retinal development
and disease (Corbo et al., 2010; Hao et al., 2012; Yang et al., 2015).
The integration of heterogeneous “omics” data poses major
challenges for delineating the complex interplay of genes in path-
ways and networks. In-depth characterization of genes is valuable
in elucidating basic biology and has contributed substantially to ourcurrent knowledge. However, cells encompass a complex internal
spatial architecture with highly organized compartments, and
genes (and their products) do not function in isolation. NGS rep-
resents a unique opportunity for investigating genome-scale data
sets to build system-level gene networks. The ﬁeld of vision in
general, and retina in particular, has undergone an extensive
expansion in gene discovery, which has not been accompanied by
detailed cell- or tissue-speciﬁc global transcriptome and epigenetic
proﬁling that would permit downstream studies on genotype-
phenotype association. In Section 6, we will highlight two system
level approaches e network inference and expression quantitative
trait locus (eQTL) analysis e to extract meaningful information by
integrating large data sets.
This review primarily focuses on general aspects of NGS tech-
nology and data analysis. A list of deﬁnitions for commonly used
terms is provided in Box 1, and description of distinct ﬁle types
speciﬁc to NGS are included in Box 2. We encourage readers to
peruse the following recent reviews on NGS and its applications:
(Boycott et al., 2013; Bras et al., 2012; Conesa et al., 2016; Davey
et al., 2011; Furey, 2012; Koboldt et al., 2013; Ozsolak and Milos,
2011; Yang et al., 2015).
2. Next generation sequencing technologies
The era of genomics was born in 1977with the sequencing of the
bacteriophage phiX174 by Fredrick Sanger (Sanger et al., 1977a).
Subsequent improvements made the Sanger method the dominant
sequencing approach, which was then employed for the monu-
mentally ambitious HGP (1990e2003) (Collins et al., 2003; Watson,
1990). This endeavor required a large workforce and a 15-year
worldwide effort to sequence approximately 3 billion base pairs
of the human genome (http://www.genome.gov/11006929).
Concomitantly, a privately funded human genome sequencing
project employed a strategy of “whole-genome, random shotgun
sequencing” in which DNA fragments of known lengths were
directly cloned into vectors, sequenced, and assembled computa-
tionally (Venter et al., 2001). This approach became the standard for
DNA sequencing and evolved into NGS and associated technologies.
Notably, a handful of scientists were able to generate a complete
human genome sequence in 4 months (Wheeler et al., 2008) by
massive parallelization of the biochemical sequencing steps
(Margulies et al., 2005a). Though distinct NGS platforms employ
different approaches, all techniques make use of massive paralle-
lization of the biochemical and sequencing steps without the need
for cloning.
2.1. Applications of NGS methodology
The plethora of new applications of NGS is truly remarkable as
nearly every type of nucleic acid can be assayed by this technology
(Lander, 2011). NGS techniques can be broadly classiﬁed into ap-
plications for investigating genome, transcriptome, and epigenome.
Genomic assays include WGS, WES, and targeted resequencing of
speciﬁc regions to discover variants associated with cell function or
disease. NGS-based transcriptome analysis (RNA-seq) (Mortazavi
et al., 2008) encompasses quantitative gene expression proﬁling,
discovery of novel transcribed sequences (Trapnell et al., 2010), and
non-coding RNA species such asmiRNA and lncRNA (Graveley et al.,
2011; Guttman et al., 2009). Epigenomemethods generally focus on
chromatin structure and include DNase-seq (Yaragatti et al., 2008),
ATAC-seq (Buenrostro et al.), DNA methylation (Lister et al., 2008),
and histone modiﬁcation ChIP-seq (Barski et al., 2007). We have
also included TF ChIP-seq (Johnson et al., 2007; Jothi et al., 2008;
Lefrancois et al., 2009; Robertson et al., 2007) in the Epigenome
section.
Box 1
Glossary.
Bioinformatics:An interdisciplinary field that encompasses biology and computer science to develop resources and software that
aid in storage and analysis of omics data.
Systems biology: A discipline that focuses on understanding structure and function of biological systems on multiple stages
including molecular, cellular, tissue, and organ levels.
Personalized medicine/Precision medicine: A disease diagnosis and treatment approach that aims to provide targeted therapies
to patients based on their individual genetic architecture and disease.
Genome: Set of all genetic information in an organism.
Genomics: The study of the genome in an organism.
Transcriptome: Full range of RNA molecules (miRNA, ncRNA, rRNA, tRNA, etc.).
Transcriptomics: Large-scale study of all the Transcripts in a cell or tissue.
Epigenetics: Processes affecting gene expression that do not alter DNA sequence.
Genome-wide association studies (GWAS): A method of identifying disease-associated variants across the whole genome.
DNA Sequencing: Process of determining the sequence of nucleotides along a DNA molecule.
Whole Exome Sequencing: Sequencing of protein-coding regions of the genome.
Exome: Protein coding sequences of the genome.
Gene regulatory networks (GRNs): Logic maps that detail how genes are regulated.
Expression quantitative trait locus (eQTL): Genomic region that harbors DNA sequence variants that influence the expression
level of one or more genes.
Chromatin: A complex of DNA and proteins that compacts and organizes chromosomes within the nucleus of eukaryotic cells.
Chromatin Immunoprecipitation (ChIP): An assay used in biology to identify protein-DNA interactions, such as transcription
factors or histones, in vivo.
Single-end Sequencing: Involves sequencing from only one end of a sequencing library.
Paired-end Sequencing: Involves sequencing from both ends of a sequencing library, providing more accurate alignment and
gene/transcript abundance levels.
Multiplex Sequencing: Simultaneous sequencing of multiple sample sequence libraries in the same reaction vessel.
Fragment: A piece of DNA resulting from sequencing library construction, originally derived from DNA shearing, enzyme
digestion, tagmentation, or reverse transcription of the experimental sample.
Library: Set of all DNA fragments prepared for sequencing for an experiment.
Library size/Sequencing depth/Read depth: Number of fragments sequenced.
Sequencing Read: Output from sequencing machine of the library fragments.
Coverage: Fraction of the genome mapped by sequenced reads.
Contig: A set of overlapping reads.
Variant Calling: Process of identifying single nucleotide variants from NGS data using mathematical and computational tools.
Read mapping: Process of aligning sequence reads to a reference genome.
Transcriptome Reconstruction: Process of computational reconstruction of transcripts from sequencing reads.
Peak calling: Process of identifying genomic locations where reads align.
Single Cell Sequencing: Sequencing at a single cell level.
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In less than a decade, increased throughput of sequencing and
dramatic reduction in costs have led to NGS becoming a widely
used genomic technology. Since the release of the ﬁrst commer-
cially available system (GS20 from 454 Life Sciences) with a
throughput of 20 megabase pair (Mbp) per run (Margulies et al.,2005b), the NGS technology has improved immensely. The cur-
rent Illumina HiSeq X system is capable of producing 1.8 terabase
pair (Tbp) of sequencing data per run, nearly a 100,000-fold in-
crease within a 10-year period. During this relatively brief span,
several NGS systems such as HeliScope from Helicos BioSciences
(Thompson and Steinmann, 2010) and 454 GS FLX from Roche have
been discontinued, whereas a few others including SOLiD
Box 2
Frequently used file formats and their descriptions in Illumina sequencing workflows.
BCL (.bcl): Base call (BCL) is a binary file that is generated by Illumina sequencing instrument as an output in each sequencing
cycle. bcl2fastq tool merges per-cycle BCL files into FASTQ files that are input of many downstream sequencing analysis tools
such as aligners and de novo assemblers.
FASTQ file (.fastq or .fq): Once sequencing is completed, nucleotide sequence and quality score of each read is stored in FASTQ
text file format for further analysis steps. An example of the first four lines of a standard FASTQ file is shown below.
Line 1. @HWI-D00541:31:C75NKANXX:4:1101:1333:1963 2:N:0:GCCAAT
Line 2. GCTAGACATTGTTTTATCCAATCTCATCTTGCACTTCTCTAGCATC…
Line 3. þ
Line 4. BBBBBFFFFFFFBFFFFFFFFFFFFFFFFFFFFB/BFFB<BFBBFFFFFFFF</7B
The first line always starts with @ character and represents the sequence identifier. The second line is the biological sequence of
the read, which is composed of a four-letter nucleotide alphabet (A, T, G and C). The third line is again sequence identifier and
always starts with þ character. As in this example, the third line may sometimes consist of only a þ character. The fourth line
describes the quality score of corresponding sequencing read, which is coded with ASCII characters. We recommend readers to
look at Cock et al., 2010 article for detailed information regarding FASTQ file variants (Cock et al., 2010).
SAMfile (.sam): SequenceAlignment/Map (SAM) isa textfile that stores alignment informationof reads to referencegenomeorgiven
sequence (Li et al., 2009).Somealigners suchasSTAR (Dobinet al., 2013) generateSAMfile asanoutputof alignmentprocessof short
reads toreferencegenome.ASAMfile includesaheadersectionstartingwith@characterandalignmentsectionconsistingofmultiple
lines.
BAM file (.bam): Binary Alignment/Map (BAM) is the binary version of SAM file (Li et al., 2009). As SAM file does, BAM file stores
alignment information of reads however BAM file is compressed (has smaller size) and more efficient in many sequencing
analysis tools as it is compared to SAM file. A SAM file can be converted to a BAM file (or vice versa) with the help of SAMtools
standalone software (Li et al., 2009).
BED file (.bed): A BED file is a tab-delimited text file that might consist of multiple lines each representing a single genomic region
or feature such as an exon or gene body. There are three required fields (represented below) in a standard BED file named chrom,
chromStart and chromEnd. “chrom” stands for chromosome in which the region is located. “chromStart” represents the starting
bp of the region, inclusively, with the first bp in a chromosome designated as 0. “chromEnd” is the end position of the region,
exclusively. The other nine fields are optional and provide additional information about the genomic region such as relevant
strand information or a context-specific score. Detailed information about BED file and its variants can be found at UCSC Genome
Bioinformatics web site: http://genome.ucsc.edu/FAQ/FAQformat.
chr2 116848098 116877168
chr2 118745757 118748810
chr2 120024806 120027453
chr3 89394289 89398779
chr3 94998833 95004869
Multi-FASTA file (.fa): A multi-FASTA file is a text file that consists of multiple FASTA format sequences. Below is a simple multi-
FASTA file in which each sequence.
identifier starts with> character and followed by single ormultiple lines of biological sequence.We typically usemulti-FASTA files
of genomes and transcriptomes that can be downloaded multiple sources (e.g. Ensembl or Gencode web sites) while building
genome and transcriptome indexes in sequencing data analysis.
>Nucleotide_Sequence1
CGCGCCCGGCCCGTAGCGTCCTCGTCGCCGCCCCCCGCGGACTAGCCCGGGTGGCCTCGTCTCGCAGCCGCACTCCCCGTGAGCCC
GCGTGGACGCTCTCGCCTGAGCG.
>Nucleotide_Sequence 2
CGTAGCGCAGCGATCGGCGCCGGAGATTCGCGACACTGGCGCGCGGGCGAGCGCACGGGCGCTCACCCGACACTCCGCGCCGCC
CGCCGGCCAGGACCCGCGGCGCGACAGTCCGGCAGCGCCGGGGTTAAGCGGCCCAAGTAAATCGCGGCGCCGCGCTACAGCCAG
CCT.
> Nucleotide_Sequence3
GGCCCGCTGAGGCTTGTGCCAGACCACCTCCCCTCCCCCTTTTTGGAAACCTCAGGTACACGACATATCCAGACGCGGGAT.
GTF and GFF files (.gtf and .gff respectively):General Transfer Format or Gene Transfer Format (GTF) and General Feature Format
(GFF) are text-based annotation files that stores gene structure information of any genome. In both GTF and GFF file, each line
represents a single genomic feature (e.g. an exon structure information). A GFF file has nine required field separated by tabs, and
the first eight fields of a GTF file are same as GFF file however the ninth field is always start with two mandatory attributes named
gene_id value and transcript_id value. GFF and GTF files might be either as an input of aligner software or might be output of a
genome assembler tool. Below is example lines from a mouse GTF file downloaded from Ensembl database.
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holding on to their share in the market. The new NGS systems
include single molecule sequencers (e.g., RS (Eid et al., 2009) from
Paciﬁc Biosciences and minION (Clarke et al., 2009) from Nano-
pore), which can provide high read lengths and resolution of DNA
modiﬁcations. Table 1 lists currently available sequencers and their
technical speciﬁcations. The juggernaut of the industry are the
sequence-by-synthesis (SBS) (Bentley et al., 2008) systems from
Illumina that boast awide range of applications, relative ease of use,
multiple levels of throughput, ﬂexibility in conﬁguration, and
relatively low sequencing cost. Thus, the following sections will
focus on Illumina sequencing technology.2.3. Illumina sequencing methodology
The NGS technologies using the Illumina platform employ a
massively parallel SBS methodology which involves sequencing the
ends of millions, or even billions, of DNA fragments in parallel and
performing read assembly for analysis. The routine sequencing
protocol includes three steps: sample library construction, cluster
generation, and SBS. All sample libraries are composed of double-
stranded DNA inserts ﬂanked by known adapter sequences
capable of hybridizing to the oligonucleotides on the Sequencer’s
ﬂow cell surface. The ﬂow cell is the heart of the technology, con-
sisting of a thick, glass ﬂuidic device, reminiscent of a microscope
slide, with single or multiple channels (lanes) coated with a lawn of
two designed oligonucleotides (Fedurco et al., 2006; Turcatti et al.,
2008). Cluster generation proceeds when denatured DNA libraries
are allowed to randomly hybridize to the oligonucleotide lawn in
the channels by their adapter ends (Fig. 2A). A covalently attached
DNA fragment is created by extension of the ﬂow cell oligonucle-
otides using the hybridized library fragment as a template. The
original library strands are then denatured and washed away,
leaving only the newly synthesized strand. A complementary copy
of the covalently bound strand is then generated through bridge
ampliﬁcation, a process by which the strand bends to hybridize to
an adjacent and complementary oligonucleotide, thereby allowing
the polymerase to extend the complementary strand. DenaturationTable 1
Technical speciﬁcations of four major sequencing platforms.
Sequencing platform Total output
(bases per run)
Total reads
(million per run)
Read l
(bases
Illumina HiSeq X 1.6e1.8 Tb 6000 M 2  15
MiSeq 300 Mbe15 Gb 50 M 2  30
Life technologies Solid 5500 Systems 80 Gbe320 Gb 1200 Me2400 M 50e2
Ion Torrent 520 Chip 600 Mbe2 Gb 3e5 M 200e4
Ion Torrent 540 Chip 10e15 Gb 60e80 M 200e4
PacBio Sequel System 500 Mbe16 Gb 55e880 M up to
PacBio RS II 500 Mbe16 Gb 55e880 M up to
Nanopore PromethION up to 12 Tba 1250 Ma 230e3
MinION up to 42 Gba up to 4.4 Ma 230e3
a Measured at “fast” mode in which 500 bases pass through the pore per second.then results in two covalently bound complementary copies of the
original DNA fragment. Bridge ampliﬁcation is repeated 24 times to
produce clusters of DNA clones in which half of the molecules
represent the forward orientation and the other half the reverse.
The reverse orientation strands are then cleaved and washed away
leaving only clusters of identical forward strands (ready for SBS). A
sequencing primer ﬂanking the unknown insert region is hybrid-
ized just prior to the SBS. Fluorescently labeled and reversibly
terminated nucleotides are then ﬂowed across the lawn of clusters
allowing only the ﬁrst nucleotide base to be incorporated (Fig. 2B).
The clusters on the ﬂow-cell surface are then imaged by laser
excitation, revealing a single color corresponding to the incorpo-
rated nucleotide. The ﬂuorophore is cleaved off after imaging, and
the terminator is reversed allowing for the incorporation of the
next base. This process is repeated until the predetermined
sequence (read) length is reached. The Illumina technology allows
for single-end (SE) or paired-end (PE) sequencing and single or dual
indexing of libraries for multiplex (multiple) loading of libraries. In
PE sequencing both ends of the DNA insert are sequenced, gener-
ating two reads per library fragment. To generate a second read,
another round of bridge ampliﬁcation is then performed, followed
by cleavage of the forward strand, prior to performing the second
round of SBS. Both reads are processed together computationally.
To take full advantage of the massive numbers of clusters generated
in each experimental run and reduce costs, and depending on the
depth of sequencing required, many samples can be multiplexed
and sequenced simultaneously. The adapters of each library may
contain distinct index sequences that are used to identify the li-
brary from which each read originates. Up to 24 libraries may be
pooled together in each lane of the ﬂow cell using single indexing,
and as many as 96 libraries combined when dual indexing is used.2.4. NGS experimental design
Careful planning can maximize the success of NGS experiments,
yielding useful data for extracting biologically relevant information.
In addition to the basic precepts, such as the number of samples,
replication and controls, the experimental design should considerength
)
Run time
(days)
Purpose/deﬁnition
0 bp <3 Allows sequencing of larger genomes (e.g., mammalian
genomes) at population level
0 bp 0.2e2.7 Designed for particularly small genomes (e.g., bacterial
genomes) and amplicon sequencing
 50 bp 7 Offers application-per-lane sequencing that allows
transcriptome, exome and genome sequencing
concurrently in a single run. Additionally, pay-per-lane
sequencing feature makes Solid 5500 Systems cost-effective
because reagents are not required for unused lanes.
00 bp 0.1 Ion S5 System allows generation of diverse sequencing data
ranging from targeted re-sequencing to genome sequencing
with as little as 10 ng sample.
00 bp 0.1
60 kb <0.1e0.3 Useful in the studies of de novo assembly of large genomes.
Sequel System can be utilized for generating variation,
expression and/or regulation related sequencing data.
60 kb <0.1e0.3 Much more suitable for sequencing small genomes
although animal and plant genomic studies is also possible.
00 kba 2 Ideal for large sample numbers. PromethION can sequence
up to 48 samples in a single run
00 kba 2 Portable sequencing instrument. MinION can be run with a
desktop or laptop computer and data can be performed in
real time.
Table 2
Capture technologies for WES.
Platform Target capture
region length
Bait
length
Bait
density
Notes
NimbleGen 64.1 Mb Not
Available
2.8 Mb Requires 1e2 mg of DNA, utilizes overlapping biotinylated DNA probe design. Adapter addition is through ligation.
Agilent 51.1 Mb 66.48 Mb 1.63
e3.5 Mb
Requires 2e3 mg of DNA, utilizes biotinylated cRNA as bait from non-overlapping probes that are directly adjacent to
each other. Adapter addition is through ligation.
Nextera 62.08 Mb 33.01 Mb 1.44 Mb Requires 50 ng of DNA. The gapped capture probes rely on paired-end reads to extend outside the bait sequences and
to ﬁll the gaps. Utilizes transposons for fragmentation and adapter ligation without the need of mechanical shearing.
TrueSeq 62.08 Mb 33.01 Mb e This capture platform from Illumina is similar to Nextera except that the input requirement is higher (1 mg) and
ultrasonication is used for DNA fragmentation.
Fig. 2. Illumina sequencing and data processing workﬂow. A. Denaturated NGS library fragments are ﬂowed across a ﬂow cell and hybridize on a lawn of complementary Illumina
adapter oligos. Complementary fragments are extended, ampliﬁed via bridge ampliﬁcation PCR, and denaturated, resulting in clusters of identical single-stranded library fragments.
B. Fragments are primed and sequenced utilizing reversible terminator nucleotides. Base pairs are identiﬁed after laser excitation and ﬂuorescence detection. C. Raw data is
demultiplexed into individual libraries and assessed for quality. Removing adapter reads reduces technical noise. Finally reads are aligned onto assembly of interest.
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Fig. 3. WES workﬂow and analysis. Genomic DNA from cells or tissue is tagmented
using hyperactive Tn5 transposase coupled with Illumina sequencing adapters as
described in (http://www.illumina.com/products/nextera-rapid-capture-custom-
enrichment-kit.html). After PCR ampliﬁcation, DNA probes speciﬁc to exonic se-
quences are used to isolate coding sequences using two-step hybridization. Library
ampliﬁcation with index primers allow for multiplexing a variety of libraries in the
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length of sequence reads, whether PE or SE sequencing is more
appropriate, and which samples are combined for multiplexing. PE
sequencing is usually preferred to SE sequencing because of gain in
coverage and enhanced accuracy of alignment, especially for
mapping and quantiﬁcation of RNA-seq data. Long sequencing
reads (over 50 bp) are not needed for miRNA-seq and epigenomic
assays, and SE sequencing may be sufﬁcient in many experiments.
In addition to a reduction in costs, multiplexing of samples can
minimize lane or NGS-run bias and should be employed based on
depth considerations. For example, it is better to pool 24 libraries
and sequence these on three lanes of a ﬂow cell, as compared to
preparing three pools of 8 libraries and sequencing each pool in a
single lane.
2.5. Basic raw data pre-processing and quality assessment
Sequencing reads from the Illumina platform are generated in a
binary base call (BCL) ﬁle format that is incompatible with most
open source analysis software. Therefore, the ﬁrst pre-processing
step involves the conversion of BCL ﬁles to the universally
accepted FASTQ format (Fig. 2C; Box 1). Only high quality reads that
successfully pass Illumina’s “Chastity Filtering” are kept for further
sequence analysis, which can be performed by a multitude of
available software. The next step in data pre-processing is to
eliminate the Illumina adapters, and poly(A) or poly(T) sequences
(added during cDNA and library preparation) that may be present
at the end of the reads. We recommend Trimmomatic software
(Bolger et al., 2014) though others such as Cutadapt and FASTX-
Toolkit can be used. Quality control (QC) software such as FASTX-
Toolkit, FastQC, NGS QC Toolkit, and PRINSEQ (Schmieder and
Edwards, 2011) are then applied to obtain crucial information
about the quality of sequencing reads including quality score dis-
tribution along the reads, GC content, read length, and level of
sequence duplication. Many of these tools can perform both
sequence trimming and QC analysis. Once the FASTQ ﬁles have been
validated, sequence alignment and bioinformatic analysis is per-
formed based on the goals of the experiment, as discussed in Sec-
tions 3e5.
3. Genome
WGS, WES, and targeted re-sequencing are powerful and rela-
tively unbiased methods for discovering disease-associated genetic
variations and genes.WGS provides a uniquewindow to investigate
genetic or somatic variations, leading to new avenues for explora-
tion of normal and disease phenotypes. However, the massive
quantity of data and the requirement of signiﬁcant computational
resources make WGS cost prohibitive for routine genetic and bio-
logical studies at this stage (as of March 2016). In contrast, WES
focuses on capturing and sequencing protein-coding regions
(exomes), limiting the data to a more functionally informative part
of the genome. WES has become a popular choice for genetic
studies, primarily for disease gene identiﬁcation and clinical diag-
nosis, yielding coding and splice-site variants from a large number
of samples within a relatively short time-span (e.g., WES of 96
samples can be completed within a week). This method is best
suited for identifying highly penetrant variants associated with
Mendelian diseases. Targeted re-sequencing involves the capturesame sequencing ﬂow cell. After sequencing and read mapping steps, PCR duplicates
are removed using available computational tools. Realignment around indels, base
recalibration, variant calling and annotations are all WES-speciﬁc computational
processes to extract variant information.
Table 3
Commonly used tools for RNA-Seq data analysis workﬂow.
Process Tool Description
Short read
alignment
Splice-
unaware
BWA BurrowseWheeler Transform algorithm based tool that accurately maps reads (up to 1 Mbp) to a given reference genome.
Bowtie2 Memory-efﬁcient aligner for mapping very short reads (ranging from 50 to 100bp) to large genomes.
Splice-
aware
TopHat2 Short read aligner for the discovery of novel splice sites at exon-exon junctions.
STAR Spliced read aligner for de novo identiﬁcation of novel splice junctions. STAR is signiﬁcantly faster at read mapping
compared with other sequence aligners.
Transcript
assembly
De novo Trinity Full-length transcript assembler for the identiﬁcation of novel transcripts from Illumina RNA-seq data. Trinity uses a de
Brujin graph-based method for the construction of transcript structures and provides accurate transcript assemblies when a
reference genome is unavailable.
Oases Short read assembler for RNA-seq samples with missing reference genomes. Oases enables the discovery of novel exon
structures in previously undescribed transcripts from Illumina, SOLID and 454 data.
Ab initio Cufﬂinks Transcriptome analysis suite for RNA-seq assembly as well as quantiﬁcation and differential expression analysis. Cufﬂinks
assembles short reads and predicts novel exon structures on the reference genome.
Scripture A tool developed for stringently describing abundantly expressed novel transcripts. It is more appropriate to use Cufﬂinks
instead of Scripture to identify non-coding RNA that are generally expressed at low levels (Cabili et al., 2011).
Quantiﬁcation eXpress A transcript quantiﬁcation tool based on the Expectation Maximization (EM) algorithm for estimation of transcript-level
abundances. Additionally, it provides analysis diverse options for allele-speciﬁc expression, ChIP-seq and metagenomic
data.
RSEM Another commonly used EM algorithm-based tool for accurate quantiﬁcation of transcripts. RSEM is also capable of
estimating gene-level expression levels.
Kallisto An ultra-fast and alignment-free transcript quantiﬁcation tool. Kallisto can approximate expression levels of transcripts in
minutes on a standard desktop computer using a pseudoalignment approach, and it does not require large memory for
quantiﬁcation relative to other quantiﬁcation tools.
Cuffquant Developed as a part of Cufﬂinks. Cuffquant calculates a gene expression table at the transcript level. The output of Cuffquant
may be used as an input to Cuffdiff 2 once properly normalized using Cuffnorm.
Differential expression Cuffdiff 2 Differential expression analysis tool, part of the Cufﬂinks transcriptome analysis suite, for group comparison at transcript
resolution. Cufﬂinks 2 supports robust alternate splicing and differential promoter usage analyses.
edgeR An R/Bioconductor package for performing count-based differential expression analysis. edgeR provides diverse statistical
test options, including generalized linear models and negative binomial distribution based modeling. It is also suitable for
differential analysis of other data types i.e. ChIP-seq and proteome peptide count data.
DESeq Another R/Bioconductor package for statistical analysis of replicated high-throughput count data. DESeq is built on a
negative binomial distribution model and can also be utilized for differential expression at exon level resolution to resolve
splice event differences between samples.
limma A linear modeling-based tool for testing differential gene expression for both microarray and RNA-seq data. limma is an R/
Bioconductor package that provides diverse functionalities to users, including data-preprocessing, transformation and
normalization.
Alternate splicing analysis MATS Detects altered exon usage. MATS uses a Bayesian statistical model for testing differential splicing events between groups
and offers statistical signiﬁcance testing individually for each possible event using a Markov chain Monte Carlo method.
Diffsplice A computational tool for the identiﬁcation of splicing patterns without transcript annotation data or pre-deﬁned splicing
motifs. Diffsplice utilizes a non-parametric approach to summarize signiﬁcance level of differential splicing events.
SplicingCompass An R package that identiﬁes differential alternative splicing events at the gene level rather than exon level. SplicingCompass
creates a read count vector for each gene and calculates geometric angles between the vectors for discovering potential
spliced genes.
DSGseq A negative binomial model-based tool that uses exon read counts for two-group comparison of alternative splicing
signatures. DSGseq supports the identiﬁcation of novel splicing events as well as differential splicing.
Table 4
Commonly used tools for variant analysis.
Process Tool Description
Variant
calling
CRISP Compares allele count distribution across multiple pools or evaluates the probability of identifyingmultiple non-reference base calls occurring
due to sequencing errors to identify variants.
GATK Built to process data originating from Illumina sequencing technology, but can be adapted to other sequencing technologies. Implements
MapReduce functionality to achieve parallelism for faster data processing.
SAMTOOLS Can identify variants from single ormultiple samples. BCFtools utility in SAMTools suite is used to identify SNPs and short INDELs from a single
alignment ﬁle.
SNVer Implements binomialebinomial model for signiﬁcance testing of inferred allele frequency against sequencing error.
VarScan 2 A heuristic and statistical algorithm that detects and classiﬁes variants based on somatic status.
SomaticSniper Implements Bayesian Statistics to compare liklihoods of genotypes in cases and controls obtained from existing germline genotyping
algorithm.
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and WGS. In this review, we focus on WES, describing various
capture methods, computational tools and applications.3.1. Whole exome sequencing
Whole exome sequencing (WES) involves capture and
sequencing of the coding regions (the exomes) of genome (Ng et al.,
2009; Priya et al., 2012). WES has become the method of choice formutation identiﬁcation since a majority of disease-causing variants
for monogenic disease are detected in the protein-coding regions
that comprise less than 2% of the genome (Bamshad et al., 2011).
Currently, four major exome capture/enrichment kits are available:
Nextera Rapid Capture Exome and TruSeq exome enrichment (both
from Illumina), SureSelect XT Human All Exon (Agilent), and Seq-
Cap EZ Human Exome Library (Roche/NimbleGen). They differ in
the target selection regions, bait (capture probe) length, bait den-
sity used for capture of exonic sequences, and the total number of
Table 5
Web links (in alphabetical order) of resources & tools.
Resource/tool URL
ANNOVAR www.openbioinformatics.org/annovar/
BEDOPS https://bedops.readthedocs.org/
Bedtools http://bedtools.readthedocs.org/en/latest/
Biomart http://www.ensembl.org/biomart/
Biowulf https://hpc.nih.gov
Bowtie2 http://bowtie-bio.sourceforge.net/bowtie2/index.shtml
CADD database http://cadd.gs.washington.edu/
ChIPQC https://github.com/Bioconductor-mirror/ChIPQC
CuffDiff 2 http://cole-trapnell-lab.github.io/cufﬂinks/cuffdiff
Cufﬂinks http://cole-trapnell-lab.github.io/cufﬂinks
Cutadapt http://dx.doi.org/10.14806/ej.17.1.200
dbSNP http://www.ncbi.nlm.nih.gov/SNP/
DiffBind http://bioconductor.org/packages/release/bioc/html/DiffBind.html
Diffsplice http://www.netlab.uky.edu/p/bioinfo/DiffSplice
DREME http://meme-suite.org/tools/dreme
DSGseq http://bioinfo.au.tsinghua.edu.cn/software/DSGseq
EdgeR https://bioconductor.org/packages/release/bioc/html/edgeR.html
ESP6500 http://evs.gs.washington.edu/EVS/
ExAC http://exac.broadinstitute.org/
FastQC http://www.bioinformatics.babraham.ac.uk/projects/fastqc/
FASTX-Toolkit http://hannonlab.cshl.edu/fastx_toolkit/index.html
F-Seq https://github.com/aboyle/F-seq
Hotspot https://github.com/rthurman/hotspot
HPeak http://csg.sph.umich.edu//qin/HPeak/
MACS2 https://github.com/taoliu/MACS
MATS http://rnaseq-mats.sourceforge.net
MEME http://meme-suite.org/tools/meme
NGS QC Toolkit http://www.nipgr.res.in/ngsqctoolkit.html
Oases http://www.ebi.ac.uk/~zerbino/oases
ODIN http://www.regulatory-genomics.org/odin-2/basic-introduction/
PeakSeq http://info.gersteinlab.org/PeakSeq
Peakzilla https://github.com/steinmann/peakzilla
Picard http://broadinstitute.github.io/picard/
Proﬁling (GERP) score. http://mendel.stanford.edu/SidowLab/downloads/gerp/
Retnet https://sph.uth.edu/retnet/home.htm
RNA-STAR http://code.google.com/p/rna-star/
Samtools http://samtools.sourceforge.net/
Scripture https://www.broadinstitute.org/software/scripture
SnpEff and http://snpeff.sourceforge.net/
SplicingCompass http://www.ichip.de/software/SplicingCompass.html
SPP https://github.com/hms-dbmi/spp
STAR https://github.com/alexdobin/STAR
Tophat https://ccb.jhu.edu/software/tophat/index.shtml
Trimmomatic http://www.usadellab.org/cms/?page ¼ trimmomatic
Trinity https://github.com/trinityrnaseq/trinityrnaseq/wiki
Variant effect predictor http://www.ensembl.org/Homo_sapiens/Tools/VEP
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instance, NimbleGen, and Agilent targets cover 64.1 Mb and
51.1 Mb, respectively, whereas the two Illumina platforms target
62.08 Mb of the human genome. The four kits only share 26.2 Mb of
the total targeted nucleotides. We have used Nextera Rapid Capture
Exome platform extensively. Brieﬂy, this protocol uses transposase-
mediated fragmentation and adapter ligation using 50 ng of DNA,
followed by two rounds of exome capture with biotinylated DNA
baits complementary to the target exomes (Fig. 3). A performance
comparison of the four platforms demonstrated high target
enrichment for the consensus coding sequence (CCDS), with the
Nextera exhibiting a sharp increase in read depth for GC-rich se-
quences compared to other technologies (Chilamakuri et al., 2014).
WES is relatively comprehensive, inexpensive, and rapid for
identifying coding and splice site mutations compared with other
variant detection methods and adopted extensively in clinical di-
agnostics. However, several limitations exist. None of the WES
capture probe sets seem to target all of the exons listed in the
Consensus Coding Sequence project (CCDS) (Farrell et al., 2014),
RefSeq (O’Leary et al., 2016), or Ensembl (Cunningham et al., 2015)
databases. The capture step is not uniform and tends to have biasagainst high GC rich regions. In addition, identiﬁcation of variants is
restricted by capture design, which would generally skip unanno-
tated or as yet unidentiﬁed exons and variants residing in the non-
coding and/or regulatory region of the genome. Furthermore, only
92e95% of exons are captured in WES and mutations may be
missed even if the region is included in the capture probe design.
Capture kits are also not very efﬁcient in identifying structural
variants such as translocations and inversions.
3.2. Primary analysis of WES data
After quality control analysis of NGS data (described in Section
2.5), we have four additional steps in our WES pipeline to identify
genomic variants with high accuracy (Fig. 3).
3.2.1. Sequence alignment
The short reads generated in the NGS methods are ﬁrst aligned
to a reference genome with mapping tools (Table 3), such as BWA
and STAR, producing sequence alignment/map (SAM) ﬁles. Accu-
rate and efﬁcient mapping of WES data is essential for variant
identiﬁcation.
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The post-processing steps are required to minimize the number
of false positive variants arising in the WES data and include the
removal of duplicate reads generated by PCR ampliﬁcation,
realignment around insertion-deletion variants (indels), and base
quality recalibrations. Local realignment of the BAM ﬁles is essen-
tial to minimize the mismatching bases, thus eliminating false
positive single-nucleotide variants near indels. This extended post-
processing realignment step is not required for transcriptome and
epigenome data analysis. Finally, base quality recalibration adjusts
the quality score of each base using the known variants in a data-
base and helps improve the accuracy of variant calling.
3.2.3. Variant analysis
A number of open source tools are available for variant calling
(Table 4). Application of sample variant calling software is recom-
mended to reduce false positive variants. We can also improve
variant calling in regions with fewer reads by utilizing reads from
multiple samples concurrently.
3.3. Secondary analysis
The primary analysis of WES data provides a large number of
genomic variants. Additional steps are needed to understand the
role of these variations in the context of the disease trait under
investigation. These steps include variant annotation, estimation of
variant incidence in the population (frequency), and customized
ﬁltering steps to identify candidate disease-causing variants
(variant prioritization).
3.3.1. Variant annotation
A single exome analysis can reveal 20,000e30,000 variants.
Thus, assigning functional information (annotation) to the variants
is important. The ﬁrst step in gene annotation focuses on deter-
mining whether a single nucleotide variant reﬂects synonymous,
non-synonymous, non-sense codon, or consensus splice site
changes. In addition, a variant can be an indel that may impact
transcript structure. The next step involves estimating the inci-
dence (minor allele frequency, MAF) of the variant in the general
population. Large-scale genomic studies such as the 1000 Genomes
Project, ESP6500, dbSNP, ExAC (Table 5) have catalogued sequence
variants from thousands of exomes and genomes, which serve as a
valuable resource for allele frequency estimations. Another aspect
of annotation includes base conservation and functional pre-
dictions, which can be accessed using LJB23 database (Liu et al.,
2011), Combined Annotation Dependent Depletion (CADD) data-
base, and Genomic Evolutionary Rate Proﬁling (GERP) score
(Table 5). Three major tools are used to classify variants: ANNOVAR,
SnpEff and Variant Effect Predictor (Table 5). The choice of software
and reference transcript annotation can have a large impact on
variant interpretation (McCarthy et al., 2014). ANNOVAR is a pop-
ular software for variant analysis because of its capability to inte-
grate most of the functions discussed here (Yang and Wang, 2015).
3.3.2. Variant prioritization
Identiﬁcation of a disease causing or associated variant in exome
sequencing experiments requires a customized ﬁltering process
depending on the question being pursued, as discussed below. A
number of reviews provide general recommendations for identi-
fying disease variants (Bamshad et al., 2011; Ratnapriya and
Swaroop, 2013).
3.3.3. Filtering WES data in Mendelian/monogenic diseases
Traditional positional cloning methods for identifying Mende-
lian disease genes involve collecting large pedigrees, performinglinkage analysis to map the disease locus, and screening candidate
genes for a segregating rare variant. This process is time consuming
and requires a minimum number of individuals to reach statistical
signiﬁcance in linkage analysis. WES and targeted re-sequencing
have dramatically altered the analysis landscape, and we can now
identify mutations in small families or even a single affected
individual.
The search of causal variants includes applying a cut-off for MAF
and focusing on variants with a major effect on gene function (non-
synonymous, truncation, and splice variants). Inheritance pattern is
another ﬁlter that can be applied; for example, a recessively
inherited disease variant is likely homozygous whereas a dominant
disease variant is heterozygous. However, there can be exceptions
to these rules. For instance, recessive disease variants can be
compound heterozygous. Segregation with affection status is
another critical ﬁlter that can be applied to family-based studies. In
a large cohort, the search for either identical variants or additional
rare variants in the same gene can further strengthen the evidence
for causality. WES was ﬁrst employed in vision research for the
analysis of an Ashkenazi Jewish family with three affected siblings
and resulted in the identiﬁcation of a mutation in a novel gene,
DHDDS, as a cause of retinitis pigmentosa (Zuchner et al., 2011). At
this stage, 62 retinal disease genes have been identiﬁed using WES,
three by targeted capture, and another two by taking advantage of
WGS (RetNet; see Table 5).
A rapid pace of evolution in variant detectionmethods hasmade
it possible to obtain more accurate diagnosis and prognosis in
clinical practice and yielded opportunities for precision medicine
initiatives (Amendola et al., 2016). However, previously unknown
and dynamic aspects of the genome in health and disease are
presenting great challenge for interpreting the effect of a speciﬁc
variant in causing the phenotype. Each individual carries thousands
of unique variants in the genome (Genomes Project et al., 2015).
WES of an individual can identify as many as 100 loss of function
variants that may not have any dramatic effect on the phenotype
(MacArthur et al., 2012; Sulem et al., 2015), yet many loss of
function mutations lead to lethality or disease. A large number of
variants (dozens to hundreds, depending on the study design) can
pass the ﬁltering methods described above, and determination of
causal variant(s) needs careful examination. Finding a rare variant
even in a known disease gene is not sufﬁcient to suggest causality. If
a pedigree is available, one must look into the mode of inheritance
and perform linkage or homozygosity mapping to narrow down
genomic regions to focus the search. In the absence of the family
data, one has to depend on the overall burden of rare variants in a
disease population compared to healthy controls. Distinct com-
plementary approaches can therefore help in identifying few
candidate variants and genes that must be evaluated further (using
in vivo and in vitro model systems) to elucidate their functional
impact in causing the disease.
3.3.4. Filtering in complex diseases
The analysis and ﬁltering of NGS data for a complex disease
requires a different strategy to identify candidate causal variants in
biologically relevant genes and pathways. GWAS has been a popular
method for identifying genetic risk variants in complex diseases by
comparing a large number of common and/or rare variants be-
tween individuals with a phenotype of interest (cases) and a set of
unrelated (matched) controls (http://www.ebi.ac.uk/gwas/). Such
studies have yielded a catalog of common SNPs associated with
complex diseases affecting vision (Bailey et al., 2016; Fritsche et al.,
2016; Grassi et al., 2011; Kirin et al., 2013). However, associated
alleles are not causal, andmajority of association signals are located
in the non-coding region of the genome with ill-deﬁned function
(Chakravarti et al., 2013).
Fig. 4. RNA sequencing workﬂow and analysis. Total RNA is extracted and ribosomal RNA is either removed to enrich for other RNA species, or polyA-tailed RNA are isolated using
poly(T) oligomer magnetic beads as described in (http://www.illumina.com/products/truseq_stranded_total_rna_library_prep_kit.html). RNA is then fragmented using sonication,
followed by cDNA synthesis, end repair, adapter ligation, and indexing. After PCR ampliﬁcation and library quantiﬁcation, RNA reads are mapped to known transcripts and the whole
genome to facilitate transcript identiﬁcation and quantiﬁcation. Multiple secondary analyses exist to understand the expression proﬁle of cells and whole tissues.
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evolving. AMD is one of the best-studied complex diseases, where
52 common and rare variants at 34 genetic loci have been identiﬁed
so far using GWAS and Exome-Chip approaches (Fritsche et al.,
2013; Fritsche et al., 2016). However, the pathological role of the
candidate genes or variants is not completely clear at a majority of
the AMD loci and underlying disease mechanisms are largely un-
known. Targeted re-sequencing of some of these loci has led to the
discovery of high-risk rare, coding variants, providing crucial
functional clues about causal genes. For example, a rare penetrantmutation, R1210C, was identiﬁed at the CFH locus (Raychaudhuri
et al., 2011). Rare variants in other complement genes have also
been identiﬁed in advanced AMD patients by targeted and WGS
(Fritsche et al., 2016; Zhan et al., 2013). Rare variants exhibit very
high odds ratio and are likely to be causal, as these are observed at
very low frequency in the general population. However, these
events are also rare in the disease population with few individuals
carrying the disease-causing rare coding mutation at an associated
locus. Even a genomewide survey of exome variants with low to
moderate frequency (Exome Chip) did not lead to novel
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explanations can be put forth. It is possible that the contribution of
rare variants is small and common non-coding variants with reg-
ulatory functions are indeed disease-causing. Alternatively, the rare
variants likely arise independently in genomes and a sequencing
based approach (such as WGS) focusing on all rare events, rather
than Exome Chip, might be more successful. Indeed, one would
predict that the effect of a single variant/gene is not large and thus
we must focus on biological pathways relevant to the disease
biology or an integrated approach combining transcriptome and
epigenome analysis with GWAS (discussed in Section 6).
We note that several statistical methods have been developed to
evaluate the impact of multiple independent rare variants that
cause functional damage in a combinatorial manner; these
methods can be broadly classiﬁed as burden and non-burden tests.
Burden tests collapse rare variants in a genetic region into a single
burden variable, and then model the phenotype using the burden
variables to test for the cumulative effects of rare variants in the
region. These models include collapsing methods such as CAST,
CMC, RareCover, and aSum and aggregation methods such as WSS,
KBAC, and RBT (Lee et al., 2014). Non-burden tests such as VT, C-
alpha, EREC, and SKAT (Lee et al., 2014) aggregate individual variant
score test statistics with weights when SNP effects are modeled.
3.4. Interpretation of genetic variations
Elucidating the functional impact of thousands of variants
identiﬁed in WES or other NGS studies poses major challenges for
genetic diagnosis and personalized medicine. Rules of genetics are
now being redeﬁned. Even healthy individuals have been identiﬁed
to harbor mutations in at least 8 severe Mendelian conditions but
with no phenotype (Chen et al., 2016), suggesting incomplete
penetrance and/or existence of alleles that might be protective. The
roles of synonymous (Plotkin and Kudla, 2011) and non-coding
variants (Sakabe et al., 2012) in disease causation are also
becoming evident. Contributions of more than one mutations/var-
iants in Mendelian disease are being recognized as modiﬁers
(Genin et al., 2008; Slavotinek and Biesecker, 2003), compensatory
mutations (Jordan et al., 2015) or triallelic inheritance (Eichers
et al., 2004). Modiﬁer alleles might also explain vast clinical/
phenotypic heterogeneity that is commonly observed in RDDs
(Ebermann et al., 2010; Khanna et al., 2009; Priya et al., 2014).
NGS presents immense opportunity to decipher exciting attri-
butes of human history, biology and disease than merely cataloging
primary genetic defects. Nonetheless, guidelines for systematically
investigating the causality of the variants in human disease through
functional assays are highly desirable (MacArthur et al., 2014). One
needs to take account of biological context such as tissue types and
species when designing such approaches. The lack of high
throughput functional assays has been a major bottleneck in the
ﬁeld. For years, scientists have used mice and other model organ-
isms for elucidating howgenetic defects might cause retinal disease
(Veleri et al., 2015). More recently, the use of human pluripotent
stem cells (hPSCs), especially induced pluripotent stem cells
(iPSCs), has signiﬁcantly expanded the focus on investigating hu-
man disease (Merkle and Eggan, 2013). hPSCs are becoming routine
for developmental studies and screening small molecules to rescue
disease-associated phenotypes (Kaewkhaw et al., 2015; Kaewkhaw
et al., 2016), offering immense opportunities in combination with
NGS to make precision medicine a reality in the near future.
4. Transcriptome
The pattern of gene expression in a cell/tissue can broadly
reﬂect its functional state. NGS-based expression proﬁling by RNA-seq (Marioni et al., 2008; Mortazavi et al., 2008) allows compre-
hensive qualitative and quantitative mapping of all transcripts
(Garber et al., 2011). Prior to NGS, transcriptome proﬁling tech-
niques had limited scope and accuracy and were not quantitatively
precise. Northern blotting and qRT-PCR analysis could not be
employed at genomewide scale. Expressed sequence tag (EST)
analysis (Adams et al., 1991; Gieser and Swaroop, 1992) and serial
analysis of gene expression (SAGE) (Blackshaw et al., 2001;
Blackshaw et al., 2003) were instrumental in proﬁling novel and
known transcripts but were labor-intensive and had limited
breadth and quantitative capability. Gene expression microarrays
(Brown and Botstein, 1999) have been the mainstay of genomewide
proﬁling during the last decade, yet several issues inherent to
hybridization-based methods were not easily overcome; these
included varying background noise, requirements for high RNA
amounts, dependence of annotated probe sets included on the
array, and lack of precise quantiﬁcation. The massively parallel
capabilities (as discussed in Section 2) of NGS have expanded the
scope of transcriptional landscape dramatically with miniscule
quantities of total RNA, low background noise, and quantiﬁcation
accuracy rivaling qRT-PCR, which has been the “gold-standard” for
quantitative studies.
Massive datasets produced by RNA-seq create unique compu-
tational challenges for analysis. For convenience, we have divided
the analysis in two parts e primary and secondary. The primary
analysis includes read mapping, transcriptome reconstruction,
expression quantiﬁcation (Garber et al., 2011), and differential
expression (DE) analysis. Read mapping refers to the alignment of
short reads to the reference transcriptome and/or genome.
Sequencing reads can also be used to generate contigs for de novo
assembly and novel transcript identiﬁcation. Transcriptome
reconstruction focuses on identifying different transcript isoforms.
Expression quantiﬁcation refers to evaluation of transcript abun-
dance at the gene or isoform level. Higher-level secondary analyses
are generally required to extract biologically relevant information
after the primary analysis is completed. The secondary data anal-
ysis can include DE analysis, de novo assembly, expression cluster
analysis, co-expression networks construction, and differential
alternative splicing (DAS). DE analysis aims to identify dissimilarly
expressed genes in different experimental conditions. De novo
transcript assembly permits the discovery of novel unannotated
transcribed sequences. Cluster analysis focuses on grouping the
genes based on a speciﬁc characteristic, such as co-expression or
shared biological function. Co-expression network construction
refers to elucidation of gene regulatory networks from expression
data. DAS examines differential isoform expression across the
biological samples or conditions. Thus, RNA-seq provides us the
necessary data for a comprehensive evaluation of broader tran-
scriptional landscape.
4.1. Library construction, data generation, and primary analysis
The basic steps in performing RNA-seq include library con-
struction and generation of sequence data followed by primary
analysis. Depending on the goals of the experiment (e.g., RNA
species being investigated), a meticulous experimental design is
essential for extracting biologically relevant information.
4.1.1. Library construction and data generation
RNA-seq library construction protocols include similar basic
steps, which require elimination of ribosomal RNA (rRNA), reverse
transcription of the desired RNA species, fragmentation, adapter
ligation, and enrichment (Fig. 4). A number of issues must be
considered to obtain high quality global expression proﬁles. First
and foremost, the RNA species being investigated (e.g., mRNA or
Fig. 5. Construction of co-expression networks and functional enrichment of network modules. A. Co-expressed genes (also called linked genes) can be identiﬁed and grouped into
network modules (represented with different colors). Here we demonstrate example network structures of three network modules (red, blue and turquoise), built using Weighted
Gene Co-expression Network Analysis (WGCNA) (Langfelder and Horvath, 2008). In each network module, genes are represented as nodes and co-expressed genes are linked. In co-
expression networks, it is believed that highly connected genes (also called hub genes) represent biologically signiﬁcant genes since their dysregulation may affect many other
linked genes. B. Genes with similar expression patterns tend to group in the same network module, and are more likely to be in the similar biological processes/pathways. Biological
relevance of network modules can be elucidated with diverse online functional enrichment analysis tools. Here we show the ﬁrst two most signiﬁcant Gene Ontology (GO) terms
related to each module after functional GO enrichment analysis using DAVID online tool (Huang da et al., 2009). Additionally, heatmap shows expression patterns of genes in each
network module across time points.
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dominant transcript species within any given cell/tissue; the
commonly used protocols use oligo-dT beads for enrichment of
mRNA. To minimize inherent 30 bias in this protocol (due to RNA
degradation), high quality total RNA is necessary for library gen-
eration. A widely applied method to evaluate RNA quality is by
using Agilent 2100 Bioanalyzer, which calculates RNA integrity
number (RIN) on a scale of 1e10. We recommend RNA with
RIN  7.0 for RNA-seq analysis. An alternative approach is to
eliminate rRNA using beads containing complementary rRNA se-
quences; this approach permits an unbiased examination of the
transcriptional landscape but requires a signiﬁcantly higher
sequencing depth per sample (Li et al., 2014a). The rRNA removal
protocol is also essential when investigating non-polyA transcripts
or if the quality of RNA is poor (RIN < 7.0). Nonetheless, this
approach allows successful analysis of even substantially degraded
RNA (Li et al., 2014a). We should mention that genomic DNA
elimination is required for this protocol prior to reverse
transcription.
The library preparation protocol should keep the ﬁdelity of the
genomic strand from which it is transcribed for correct alignment
and assignment of sequencing reads to speciﬁc transcripts since
many genes have overlapping transcribed regions on the same or
opposite strand of the genomic DNA; therefore, a directional library
protocol is necessary (Brooks et al., 2012). The desired length and
depth of the sequencing depends on the RNA species being inves-
tigated. For example, 10e50 million sequence reads are sufﬁcient
for quantiﬁcation of almost all of the known protein coding tran-
scripts. Over 100 million sequence reads per sample might be
necessary to evaluate low to moderately expressing novel tran-
scripts or for non-polyA RNA species. The sequencing depth for
mature miRNA libraries can be as little as 1e10 million reads.
Except for miRNA, longer sequence lengths are desirable for
sequencing reads to overlap neighboring exon boundaries (i.e., to
cross over the intron) thereby leading to more accurate transcript
assignment. In addition, PE sequencing can lead to more accurate
read alignments for mRNA proﬁling.
The amount of starting RNA is an important consideration
before initiating a speciﬁc library preparation protocol. We gener-
ally use 20e100 ng of total RNA for standard oligo-dT enrichment
protocol and perform paired end sequencing to produce at least 30
million directional sequence reads. Although many library kits are
available, we use the following kits: TruSeq Stranded mRNA Library
Prep Kit (Illumina) for mRNA, TruSeq Stranded Total RNA Library
Prep Kit (Illumina) for total RNA, TruSeq Small RNA Library Prep Kit
for miRNA, and SMARTer Ultra Low Input RNA Kit (Clontech) and
Nextera XT DNA Library Preparation Kit (Illumina) for single cell or
low amounts of starting RNA.
4.1.2. Sequencing read alignment
Alignment of RNA-seq reads is the crucial ﬁrst step in tran-
scriptome proﬁling. Over 90% of human transcripts are derived
from more than one exon (Harrow et al., 2012); therefore, at least
some of the reads must cross over introns and include exon-exon
junctions for determining proper transcript structure. Early align-
ment algorithms used a priori knowledge of known splice junction
sites for aligning RNA-seq reads to the genome but lacked the
ability to discover novel or rare splice events. More recent ap-
proaches include the alignment of sequence reads to a reference
transcriptome prior to the reference genome, which can overcome
multiple mapping issues associated with pseudogenes. We have
effectively performed spliced read alignment using TopHat2
(Trapnell et al., 2009), and STAR (Kim et al., 2013). TopHat was one
of the ﬁrst algorithms that performed spliced-read alignments and
also aligned reads to novel transcript isoforms and genes. Morerecently, STAR has become popular due to its successful alignment
of spliced-reads, accuracy, and speed (Engstrom et al., 2013). In
addition, STAR can now provide concurrent gene level quantiﬁca-
tion. Whole transcriptome level sequence alignments can be
completed within minutes with appropriate computer conﬁgura-
tions and memory (e.g., using 4 cores and 72 Gb RAM on Biowulf
computing cluster of NIH - https://hpc.nih.gov).
4.1.3. Gene and transcript quantiﬁcation
Successful secondary transcriptome analysis is facilitated by
accurate quantiﬁcation of RNA-seq reads, which can be performed
at the gene or transcript level depending upon study objectives.
Gene-level quantiﬁcation summarizes read counts assigned to co-
ordinates of genomic features such as genes and exons and is
appropriate in cases where considerable 30 bias exists in the data,
short and/or single-end sequencing reads (e.g., <50 nucleotides)
with low read-depth (e.g., <30 million) are obtained, or the refer-
ence transcriptome is poorly annotated (such as for non-model
species). The algorithms for gene-level analysis include HTSeq
(Anders et al., 2015), featureCounts function in SubRead software
(Liao et al., 2014), RSEM (Li and Dewey, 2011), and STAR (see Table 5
for web sites). In contrast to gene-level analysis, transcript-level
algorithms additionally assign reads probabilistically to putative
transcripts of a given gene and can provide a more accurate rep-
resentation of the transcriptome state, speciﬁcally when applied to
high quality, PE sequencing reads. Software applications for tran-
script level quantiﬁcation include RSEM, Cufﬂinks (Trapnell et al.,
2010), and eXpress (Roberts and Pachter, 2013).
Regardless of the quantiﬁcation method, expression values from
the algorithms are obtained as feature counts, RPKM/FPKM (Reads/
Fragments Per Kilobase of the exon model per Million reads)
(Mortazavi et al., 2008; Trapnell et al., 2010), or TPM (Transcripts
Per Million) (Li and Dewey, 2011). Feature counts are the most basic
unit of measure and do not account for the length of a transcript or
the depth at which the sample RNA was sequenced. Thus, feature
counts are used primarily for normalization, DE analysis, and
quantiﬁcation of expression. RPKM and FPKM are used for SE or PE
sequencing, respectively, to account for the transcript length and
sequencing depth, thereby allowing comparison across samples.
Normalization (discussed later) of the counts is essential prior to
calculating RPKM/FPKM values to reduce the disproportionate
impact of highly transcribed genes. TPM calculates the relative
abundance of a transcript by normalizing for sequence depths of
speciﬁc transcripts rather than of the whole transcriptome dataset;
it is thus a preferred metric for quantifying gene/transcript abun-
dance (Alamancos et al., 2015; Burns et al., 2015; Shalek et al.,
2013).
4.2. Secondary data analysis
Primary analysis of RNA-seq yields genome-aligned reads (BAM
ﬁles) and quantiﬁed expression data that provides basic informa-
tion on transcribed sequences. However, additional bioinformatic
analysis is required for deciphering molecular insights into cellular
functions. Here, we have focused on comparative analysis of tran-
scriptomes, identiﬁcation of novel transcripts and isoforms, dif-
ferential alternative splicing (DAS), and generation of co-expression
networks.
4.2.1. DE analysis
DE analysis is generally used to compare transcriptomes of two
or more groups of samples. From simple two-group comparison
(sample A versus sample B) to more complex multivariate analyses,
one needs to be aware of various considerations that make DE of
RNA-seq different from microarray or qRT-PCR. Before performing
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transcripts or genes (e.g., those expressed at <1 FPKM), normalize
for differences in sequencing depth, model overdispersion, and
experimental factors. The data is then subjected to DE analyses
using various tools that provide fold change in gene expression and
statistical signiﬁcance.
Typically, a large number of genes or transcripts are not
expressed at high enough levels to be considered above back-
ground noise and are eliminated to avoid an adverse impact on
normalization algorithms. This ﬁlter can be set to an arbitrary
number, such as 1 count per million or 1 FPKM in 10% of the
samples or even all replicates in any group. In retina RNA-seq data,
this ﬁlter can remove as much as 40e50% of all annotated tran-
scripts (Brooks et al., 2012). Normalization is then required to ac-
count for differences in sequencing depth. It uses various
algorithms, such as median, upper quartile, full quantile (Bullard
et al., 2010), relative log expression (RLE) (Anders and Huber,
2010), or trimmed median of the mean (TMM) (Robinson and
Oshlack, 2010). Alternatively, RNA spike-in or housekeeping gene
matrices may be used for normalization (Jiang et al., 2011; Risso
et al., 2014). We ﬁnd TMM to be widely applicable for our DE an-
alyses (Conesa et al., 2016). After normalization, FPKM values are
exported for secondary analyses including clustering and inference
of co-expression network(s).
The count data generated from digital gene expression experi-
mentations, such as SAGE and RNA-seq, demonstrate more vari-
ance than what is expected from a Poisson distribution model
(overdispersion) (Robinson and Smyth, 2007), leading to an in-
crease in type-I error (false positives) in DE analysis. This observed
overdispersion should be compensated prior to DE analysis since
traditional DE algorithms, such as student’s t-test and ANOVA, as-
sume a normal distribution of data. Several software packages can
perform this task utilizing different methodologies; these include
DESeq (Anders and Huber, 2010), edgeR (Robinson et al., 2010),
Cuffdiff 2 (Trapnell et al., 2013), and limma (Law et al., 2014). After
evaluating various methods, we have settled on limma for our DE
analysis. The ﬂexibility in the limma package allows us to model
many different experimental factor conﬁgurations, minimize type-I
errors, and permit the correction of experimental batch factors. The
ﬁnal steps in DE analysis are to ﬁlter the data for fold change and
determine statistical signiﬁcance. We initially set thresholds to
have two-fold or greater change and a false discovery rate (FDR) of
less than 5%.
4.2.2. Co-expression network inference
Co-expression networks can be developed based on expression
patterns in transcriptome data sets; e.g., if two genes exhibit a
strong correlation in their pattern of expression, these genes are
predicted to demonstrate similar transcriptional regulatory mech-
anisms (Fig. 5). A number of co-expression network inference al-
gorithms have been developed, including Boolean Networks,
Probabilistic Boolean Networks, Bayesian Networks, Dynamic
Bayesian Networks, Differential Equations Methods, Linear
Methods, Neural Network Methods and Information Theoretic
Methods (see (Hecker et al., 2009) for a review).
A systematic performance analysis of network inference ap-
proaches concluded that no single method can be used on data sets
to obtain high conﬁdence networks and that multiple inference
methods may yield complementary information which can be
combined for constructing a biologically relevant co-expression
network (Marbach et al., 2012a). After evaluating different ap-
proaches, the average rank method was implemented for inte-
grating networks generated by distinct algorithms (Marbach et al.,
2012a). The quality of network(s) inferred by the average rank
method depends on the quality of the data sets and efﬁciency ofprediction algorithms.
4.2.3. Analysis of alternatively spliced transcript isoforms
Alternative splicing (AS) generates extensive transcript diversity
in mammals by producing multiple RNA molecules from a single
gene. As many as 95% of human and other mammalian genes with
multiple exons undergo AS (Pan et al., 2008; Wang et al., 2008),
contributing to cellular and phenotypic complexity during devel-
opment and disease (Revil et al., 2010; Singh and Cooper, 2012).
While exon-microarrays ﬁrst introduced genomewide proﬁling of
distinct transcripts, NGS-based RNA-seq technology has dramati-
cally accelerated the identiﬁcation of novel transcript isoforms
generated by DAS events. A number of computational tools have
been developed for DAS analysis to obtain valuable information on
skipped exons, alternative 50 and 30 splice site usage, mutually
exclusive exons, and intron retention in transcribed sequences.
DAS analysis tools can be classiﬁed as count-based or multi-
reads, depending on the methods for quantiﬁcation of isoform
levels (Pachter, 2011). In the count-based models, the total number
of reads uniquely mapped to each genomic feature (exons in DAS
analysis) is counted individually before testing for the statistical
signiﬁcance of count difference between the control and experi-
mental groups. On the contrary, the reads can be mapped to mul-
tiple isoforms in the multi-reads model, which then test the
difference in relative transcript abundance statistically across
distinct conditions. DAS analysis requires higher sequencing depth
compared with differential expression analysis, as much as 100
million reads of 101 nucleotides PE sequencing (Liu et al., 2013).
A number of DAS analysis tools (see Table 3) permit the use of
biological replicates across different groups. MATS, DSGseq, and
SplicingCompass are count-based models, whereas Diffsplice rep-
resents multi-reads models (see Table 5 for web sites). All methods
can utilize genome-aligned reads (as SAM and/or BAM ﬁle formats)
as input, except for MATS, which can also use unaligned reads
(FASTQ ﬁle format) if the reference genome sequence is provided.
Evaluation of different DAS analysis tools with simulated and real
RNA-seq data sets has indicated that no single algorithm can
satisfactorily elucidate all possible splice events and that the choice
of DAS method is based on sample size, sequencing depth and
quality, and availability of reference transcript annotation (Liu et al.,
2014).
Regulation and functional consequences of AS can be inferred by
integrating distinct RNA-seq data sets using network based
methods (Li et al., 2014b). For example, a tensor-based pattern
miningmethod has been used to correlate exon splicing in different
genes and across diverse conditions for identifying exon clusters
that are regulated by a speciﬁc splicing factor (Dai et al., 2012). Such
co-splicing clusters indicate regulation of exon usage in different
contexts and may reveal insights into post-transcriptional control
of gene expression. Along these lines, a label propagation algorithm
can be utilized for systematic functional evaluation of distinct
transcript isoforms (Li et al., 2014c). In this approach, gene-isoform
relations are modeled by aggregating multiple co-expression net-
works of transcript isoforms into a single one and then assigning
speciﬁc roles based on their interaction with genes of known
function.
4.2.4. Novel transcript identiﬁcation using transcriptome assembly
techniques
Genome databases, such as RefSeq and Ensembl, include hun-
dreds of thousands of transcribed sequences from numerous or-
ganisms and cell lines. However, transcript catalogs of unique
neuronal cell types (e.g., distinct retinal cells) are still far from
complete. Transcriptome proﬁling by RNA-seq provides both
qualitative and quantitative depth, permitting the detection of low-
Fig. 6. ChIP and ATAC sequencing workﬂow and analysis. Retina is dissected from the eye, and cells are dissociated for follow-up studies. A. (ChIP-seq): Isolated chromatin is ﬁxed
(or unﬁxed) and fragmented as described in (Sheaffer and Schug, 2016). Magnetic beads conjugated to antibody speciﬁc to the target protein are used to precipitate fragments
bound to the protein of interest. Adapter ligation and indexing is followed by sequencing and quality control assessment. Reads are mapped onto the genome assembly and PCR
duplicates are removed to minimize experimental artifacts. Mitochondrial DNA may also be removed to improve data set comparisons. Peak calling using one of the many available
tools and DNA-binding sequencing motif analysis may facilitate the elucidation of the genome binding proﬁle for the precipitated protein. B. (ATAC-seq): Unﬁxed chromatin is
obtained and tagmented as described in (Buenrostro et al., 2013). PCR ampliﬁcation with index primers facilitates multiplexing strategies. Sequencing and mapping are followed by
PCR duplicate and mitochondrial DNA removal using available bioinformatics tools or custom scripts. Open chromatin peak calling allows for the identiﬁcation of active regulatory
regions and may be combined with other NGS data sets to improve systems integration analyses.
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and isoforms generated by alternate splicing or alternate promoterusage (Guttman et al., 2010; Kim and Salzberg, 2011; Trapnell et al.,
2010). Transcriptome assembly (also called transcriptome
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genome-guided or genome independent assembly tools (Garber
et al., 2011; Martin and Wang, 2011).
Genome-guided (also called reference-based or ab initio) tran-
scriptome assembly is utilized when high-quality reference
genome is available for the target transcriptome, and sequence
reads are ﬁrst aligned to the reference genome through a splice-
aware aligner tool, such as TopHat or STAR. The genome-aligned
reads are then assembled into transcripts using a graph-based al-
gorithm (Guttman et al., 2010; Trapnell et al., 2010). In this as-
sembly process, the ﬁrst step is clustering of overlapping reads in
each genomic region, followed by construction of all possible iso-
forms (transcripts) using one of the genome-guided assembly tools,
such as Scripture (Guttman et al., 2010) or Cufﬂinks (Trapnell et al.,
2010).
In the genome independent (also called de novo) transcriptome
assembly approach, overlapping sequence reads are ﬁrst organized
by De Brujin graph method and then assembled into transcript
structures (Martin and Wang, 2011). An accurate transcriptome
assembly in de novo approach relies upon the length of reads and
sequencing errors since no reference genome is available. Thus,
relatively longer sequence reads are preferred for a complete and
high quality de novo transcriptome assembly (Martin and Wang,
2011). Oases (Schulz et al., 2012) and Trinity (Grabherr et al.,
2011) are among the common genome independent assembly
tools, which vary in terms of their performance and sensitivity. De
novo assembly generally requires extensive computational re-
sources and long processing times depending on the size of the
transcriptome data set (Simpson and Durbin, 2012). Trinity can
perform transcriptome assembly with a reference genome in de
novo mode, which is useful when the reference genome of the or-
ganism in question does not exist or is incomplete but the reference
genome of a closely related species is available (Grabherr et al.,
2011).
Alignment and assembly steps are critical for the success of
novel transcript discovery. A large fraction of the novel assembled
transcripts do not seem to be biologically relevant and likely
represent transcriptional noise. Hence, different combinations of
aligner-assembler pairs may be utilized to obtain novel high con-
ﬁdence transcripts, which can then be validated by independent
methods including in silico replication by another assembly algo-
rithm, q-RTPCR and/or in situ hybridization. Annotations associated
with identical reference genome assembly from databases such as
Ensembl (Cunningham et al., 2015), UCSC (Karolchik et al., 2003),
and RefSeq (Pruitt et al., 2014) should be employed for accurate
identiﬁcation of novel transcripts.Table 6
Tools for analyzing NGS epigenetic data.
Process Tool Description
Quality validation fastQC/ChIPQC Ensure high
sequences a
Adapter trimming Trimmomatic Remove ada
read length)
Read alignment Bowtie2 Align reads
PCR duplicate
removal
Picard Remove rea
mtDNA removal Samtools Remove rea
DNA.
Peak calling MACS2, F-Seq, Hotspot, HPeak, SPP, PeakSeq, and
Peakzilla
Identify gen
Peak/genome
annotation
Bedtools Biomart/BEDOPS Assign peak
Motif discovery MEME, DREME, FCmotif Identify tran
Differential peak
analysis
ODIN/DiffBind Compare peTranscriptome reconstruction methods have begun to unravel
complex dynamics of transcriptomes, yet numerous challenges
remain (Guttman et al., 2010; Trapnell et al., 2010): (i) We may not
be able to detect the transcripts expressed at very low levels (e.g.,
lncRNAs) because of technical limitations, (ii) Construction of ac-
curate transcript structures is difﬁcult due to short sequence reads
from unprocessed mRNAs containing intronic regions, and (iii)
Sequence reads may be too short or not of sufﬁcient quality to
accurately map to transcriptome or genome (Martin and Wang,
2011; Trapnell et al., 2010).
5. Epigenome
Epigenome encompasses a broad array of non-genomic regu-
latory factors that do not alter DNA sequence yet play a signiﬁcant
role in modulating biological processes including development and
disease pathogenesis (Sadakierska-Chudy and Filip, 2015;
Sadakierska-Chudy et al., 2015). The analyses of epigenetic
changes associated with disease states have provided new avenues
for possible therapies of RP and AMD (Berner and Kleinman, 2016;
Zentner et al., 2015). For example, a histone deacetylase inhibitor,
valproic acid, seems to affect the severity of photoreceptor loss in
two mouse models of retinal degeneration, Rd1 and Rd10 (Mitton
et al., 2014). More recently, P300 (a histone acetyltransferase that
catalyzes acetylation of H3K27) and LSD1 (a histone demethylase
with enhancer repression functions) have been employed with
nuclease-deﬁcient Cas9 system, opening a new window of oppor-
tunity to direct epigenome editing for designing treatment para-
digms (Hilton et al., 2015; Kearns et al., 2015).
NGS technology has greatly facilitated global proﬁling of
epigenetic modiﬁcations. In this section, we will primarily focus on
chromatin immunoprecipitation followed by high throughput
sequencing (ChIP-seq) to identify DNA binding sequences for
transcription factors and to localize histone modiﬁcations, and on
DNase I digestion and transposase-mediated methods for deter-
mining chromatin accessibility (Barski et al., 2007; Buenrostro
et al., 2015; Song and Crawford, 2010). We also highlight the
guidelines and working standards for ChIP-seq and DNase-seq ex-
periments provided by ENCODE and modENCODE consortia and
describe relevant details for computational analysis of epigenetic
data.
5.1. ChIP-seq
Identiﬁcation of genomic regions occupied by DNA-binding
proteins and elucidation of chromatin state by chromatindata quality throughout the analysis pipeline. Check for overrepresented
nd Kmers.
pter sequences present in sequenced short fragments (smaller than sequenced
.
to genome in order to understand read distribution.
ds sharing exact mapping position in order to reduce PCR duplicate bias.
ds mapping to mitochondrial DNA in order to focus on epigenetics of autosomal
omic regions with a signiﬁcant overrepresentation of mapped reads.
s to genes/transcripts, or cluster genomic regions by peak proﬁles.
scription factor binding DNA motifs within peaks.
aks present in different samples to identify signiﬁcant differences.
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better understanding of regulatory factors associated with patterns
of gene expression. The ChIP-seq assay involves sonication of
formaldehyde-ﬁxed (or unﬁxed for histone modiﬁcation (HM)
ChIP-seq) chromatin from cells/tissues, followed by precipitation of
the protein or protein modiﬁcation of interest using a target-
speciﬁc antibody conjugated to magnetic beads. Double-stranded
DNA is then isolated from the precipitated protein-DNA com-
plexes and used to generate libraries for NGS (Barski et al., 2007;
Johnson et al., 2007; Sheaffer and Schug, 2016).
Identiﬁcation of antibodies speciﬁc to the protein or histone
modiﬁcation of interest constitutes the initial and critical step in
conducting transcription factor (TF) ChIP-seq or HM ChIP-seq. The
quality of the data obtained relies signiﬁcantly on the speciﬁcity of
the antibody used for immunoprecipitation of the target protein
domain from fragmented chromatin. Antibodies may show poor
reactivity to their target or bind to other DNA-binding proteins
nonspeciﬁcally, leading to false inferences of protein binding
localization (Landt et al., 2012). The ENCODE consortium recom-
mends evaluation of antibody speciﬁcity using primary and sec-
ondary tests (Landt et al., 2012). A large number of ChIP-tested
antibodies are commercially available for examining various his-
tone modiﬁcations; however, many TF antibodies are not suitable
for ChIP analysis as they either lack speciﬁcity or afﬁnity to the
target protein domain. The number of replicates for each experi-
ment and library sequencing depth are critical considerations as
well. At least two independent biological replicates should be
performed to enhance the conﬁdence in ﬁndings from ChIP-seq
datasets. The depth of sequencing depends on the size of the
genome occupied by the protein under examination (Jung et al.,
2014; Landt et al., 2012). According to the ENCODE and mod-
ENCODE consortia, point-source factors (e.g., NRL and CRX) localize
to speciﬁc points within the chromatin structure, whereas broad-
source factors (such as H3K4me and H3K36me3) have broad
chromatin footprints (Corbo et al., 2010; Feng et al., 2012; Hao et al.,
2012; Roadmap Epigenomics et al., 2015). For point-source factors,
each biological replicate is recommended to have at least 10million
uniquely mapped reads when using mammalian cells. Twenty
million reads are preferred for broad-source factors to obtain
equivalent resolution. A total of 40e50 million reads is recom-
mended for HM ChIP-seq experiments. About 500,000 to a few
million cells are required for each ChIP-seq library, including con-
trols (Sheaffer and Schug, 2016).
TF ChIP-seq has been used to proﬁle genomewide binding sites
of NRL, a transcription factor necessary for determining rod cell fate
in the mammalian retina (Mears et al., 2001), to better understand
transcriptional regulatory networks associated with rod photore-
ceptor development. The transcriptional targets of NRL include
genes involved in phototransduction, gene regulation, morpho-
genesis, and even epigenetic modulation (such as Kdm5b, a histone
demethylase involved in gene silencing) (Hao et al., 2012). CRX is
another key photoreceptor speciﬁc transcription factor that con-
trols photoreceptor differentiation (Chen et al., 1997; Furukawa
et al., 1997). The addition of CRX ChIP-seq data (Corbo et al.,
2010) to the NRL targetome has revealed an overlap of over 50%
of targets, and all known rod-speciﬁc genes appear to have binding
sites for both CRX and NRL (Hao et al., 2012).
Histone modiﬁcation ChIP-seq has been performed for whole
retina, and H3K4me2 histone marks have been observed to be
associated with active rod genes, which lack repressor methylation
H3K27me3 (Popova et al., 2014). However, whole tissue histone
modiﬁcation data might miss valuable epigenetic information on
low expressed genes and those expressed in minor cell types, and
such studies should be performed with puriﬁed cell types (Kim
et al., 2016). New methods have been developed to performsingle cell ChIP-seq experiments (Rotem et al., 2015).
We recommend high library diversity (i.e., using a variety of
indices) to take full advantage of sample multiplexing as Illumina
sequencing technology relies on the identiﬁcation of individual
DNA strand clusters via ﬂuorescence (See Section 2.3 and Fig. 2)
(Krueger et al., 2011). Illumina softwaremust locate and deﬁne each
library fragment cluster within the ﬂow cell; thus, insufﬁcient
sequence diversity within each lane of a ﬂow cell may lead to
misidentiﬁcation of closely spaced clusters with similar sequences
that may result in poor quality of data. Therefore, many distinct
samples are needed in a single ﬂow cell lane for the best read
quality in ChIP-seq experiments.
5.2. DNase-seq
DNase I digestion followed by sequencing (DNase-seq) is used to
identify genomic regions having regulatory elements such as pro-
moters or enhancers (Thurman et al., 2012; Wilken et al., 2015).
DNase I cleaves the DNA preferentially in open chromatin regions
(Cockerill, 2011; Suck, 1994) that are often considered active or
primed for activity due to their accessibility to TF binding and their
proximity to active histone marks, such as H3K27ac or H3K4me
(Ziemann et al., 2013). Thus, the ends of fragments produced by
DNase I digestion of chromatin correspond to accessible genomic
regions.
After digestion of chromatin with DNase I, adapters are ligated
to DNA fragments to produce libraries for NGS (Song and Crawford,
2010). Mapping of fragment sequences onto the genome can pro-
vide cut site frequencies at each base by counting the number of
fragments with endpoints at a speciﬁc site (Wilken et al., 2015).
Genomic regions with a high frequency of cut sites are referred as
DNase I hypersensitivity sites (DHS) that can be correlated to active
gene expression and to regulatory regions of interest. Resolution of
DNase-seq experiments may be high enough to identify genomic
regions that are protected from DNase I digestion by bound tran-
scription factors, thereby yielding possible cis-regulatory domains
associated with nearby genes. It is also possible to predict binding
of transcription regulatory proteins by searching for known
sequence motifs within TF footprints present in open chromatin
(Madrigal and Krajewski, 2012). DNase-seq has been used exten-
sively resulting in a broad range of tools speciﬁc to TF footprinting
and DHS identiﬁcation (Table 6). We also have a better under-
standing of the sequence bias of DNase I enzyme and tools have
recently been developed that take it into consideration (He et al.,
2014; Madrigal, 2015; Yardimci et al., 2014).
Genomewide proﬁling of open chromatin by DNase-seq has
demonstrated complex regional diversity in cis-regulatory domains
within mouse neural retina, cerebellum, cerebral cortex, and whole
brain (Ueki et al., 2015). Signiﬁcant overlap of DHS was observed
between brain and retina. Interestingly, DHS could be identiﬁed
even for some of the genes that are uniquely, yet highly, expressed
in small cell populations, such as S-opsin (Opn1sw) in S-cones or
Pou4f2 in retinal ganglion cells of the mouse retina; however, prior
understanding of gene regulation for cell-type speciﬁc genes is
required to extract such information. Given that neuronal tissues
contain numerous morphologically and functionally distinct cell
types, whole tissue proﬁling provides data of limited value with
respect to cis-regulatory mechanisms. We therefore recommend
DNase-seq analysis be performed with puriﬁed cell populations or
even single cells when possible.
5.3. ATAC-seq
The assay for transposase-accessible chromatin using
sequencing (ATAC-seq) may be used to identify regions of active
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2015). ATAC-seq is a three-step protocol that requires only
500e50,000 cells, compared to around 50 million required for
DNase-seq, making it a faster and more efﬁcient alternative to
DNase-seq (Buenrostro et al., 2013; John et al., 2013; Kulakovskiy
et al., 2009). ATAC-seq uses a hyperactive form of the Tn5 trans-
posase to fragment chromatin and add Illumina sequencing
adapters in a single step called tagmentation (Adey et al., 2010).
These adapter-tagged fragments are then PCR-ampliﬁed with
unique DNA index sequences. Prior to sequencing, and after PCR
cleanup using Agencourt AMPure XP beads (available from Beck-
man Coulter), the libraries are quantiﬁed using Agilent 2100 Bio-
analyzer or PCR-based methods. The former would provide library
size distribution, which may help in troubleshooting library prep-
aration methods. For high quality data, DNA quantity peaks are
clearly noticeable for fragments at 200 bp intervals corresponding
to nucleosome binding regions (Buenrostro et al., 2013). Final li-
brary concentrations may vary depending on the number of PCR
cycles and starting cell types; however, the DNA library amount
should be greater than 2 nM for sequencing on Illuima HiSeq 2500.
Paired-end sequencing enhances accuracy of alignment and
helps in identifying PCR duplicates. Read lengths for ATAC-seq ex-
periments can be limited to 34e50 bp for accurate mapping to the
genome, although larger read length may be desired for accurate
mapping onto highly repetitive genomes (Buenrostro et al., 2013;
Buenrostro et al., 2015). Sequencing depth of >50 million reads is
recommended for the analysis of open chromatin and 200 million
reads for TF footprinting.
ATAC-seq has many beneﬁts compared with DNase-seq and
produces comparable data. We note that ATAC-seq has been suc-
cessfully performed for single cell open chromatin proﬁling
(Buenrostro et al., 2015). However, computational tools needed for
Tn5 sequence bias correction (Green et al., 2012) are still under
development.5.4. Primary data analysis
The primary steps in computational analysis of epigenomic data
include evaluation of sequence read quality, adapter trimming, read
alignment, and identiﬁcation of genomic regions of interest
through peak calling (Figs. 2C and 6). First, fastQC tool (Table 6) may
be used to perform data quality analysis, producing a read report
that includes per base quality, sequence duplication levels, and
adapter content. Second, processing tools such as Trimmomatic are
utilized to remove adapter sequences that are added during library
preparation (Bolger et al., 2014). Paired-end sequencing improves
the accuracy of trimming since both forward and reverse reads
from a library fragment should contain the same amount of adapter
contamination. Third, we routinely apply the bowtie2 read align-
ment tool to map reads to genome assemblies and have observed
>75% alignments for successful TF ChIP-seq experiments in the
retina. Bowtie2 utilizes paired-end read data to improve alignment
accuracy by attempting to align the two reads from a DNA fragmentTable 7
Systems integration tools.
Method Tool
Network inference Integrative Inference Of Regulatory Network
Binding And Expression Target Analysis (BE
Integrated Regulatory Network Framework
Physical Module Networks
eQTL Matrix Eqtl
Eqtl
Genetictoolswithin a pre-speciﬁed distance from one another. This maximum
fragment length variable (deﬁned by the maxins parameter in
Bowtie2) should be larger than most library fragment lengths (e.g.,
2 kb). Finally, we observed high percentage of duplicated reads in
epigenetic data sets compared to whole genome sequencing due to
relatively small starting DNA concentrations and high number of
PCR cycles necessary in ChIP-seq and ATAC-seq experiments. These
duplicate reads confound the identiﬁcation of read-enriched re-
gions necessary for peak identiﬁcation (see Section 5.4.1)
(Dozmorov et al., 2015). Therefore, PCR over-ampliﬁcation is
examined by qPCR using an aliquot of DNA prior to library ampli-
ﬁcation (Buenrostro et al., 2015). Both Picard MarkDuplicates and
SAMtools rmdup (Li et al., 2009) functions can remove PCR dupli-
cates from the aligned reads (Table 6). Picard has the option of
identifying duplicates generated during the sequencing process
and evaluating paired-end data with paired-reads that do not align
to the same chromosome. Some of the peak callers, such as MACS,
can also ﬁnd identical reads generated during PCR (Feng et al.,
2012).
Mitochondrial DNA should also be removed using any pro-
gramming language capable of processing text efﬁciently (e.g., Perl,
Python, or Bash) if the goal is to analyze the nuclear epigenome. In
our experience, mitochondrial DNA reads may vary greatly
depending on a number of factors, including cell type, cell condi-
tion (e.g., fresh or frozen), tissue condition, and age. Changes in cell
lysis conditions and cell storage may help in reducing mitochon-
drial DNA. For comparative analysis, the data sets are normalized by
total read count to avoid any differences related to read depth.
For ATAC-seq data sets, read alignment data needs to be
compensated for 9 bp duplications that are introduced during Tn5
tagmentation step (Adey et al., 2010) (see Fig. 6B). Thus, precise cut
sites for Tn5 transposase should be determined by shifting all
positive-strand reads 4 bp downstream and all negative-strand
reads 5 bp upstream in the genome (Buenrostro et al., 2013).
Peak callers are then used to identify signiﬁcantly accessible
genomic regions (Boyle et al., 2008).5.4.1. Peak identiﬁcation
Peak-calling algorithms are often used to recognize protein-
binding sites or chromatin state in ChIP-seq and signiﬁcantly
accessible genomic regions in DNase-seq and ATAC-seq data
(Table 6). Many peak callers specialize in identifying speciﬁc pat-
terns in the data through the use of different statistical models.
MACS is a common ChIP-seq peak caller for identifying TF binding
sites and both sharp and broad histone modiﬁcation sites by
examining positive and negative strand reads that ﬂank protein-
binding regions (Feng et al., 2012; Liu, 2014). This pattern is used
to predict fragment size using a sliding window algorithm. Signif-
icantly enriched regions after peak modeling and background
correction are called peaks. MACS may also consider a control data
set to better model the background noise. Other commonly used
ChIP-seq peak callers are listed in Table 6.
F-Seq appears to be a suitable peak caller for the identiﬁcation ofAvailability
s http://compbio.mit.edu/ﬂynet/
TA) http://cistrome.org/BETA/
Available upon request to authors.
http://www.compbio.cs.huji.ac.il/PMN/Welcome.html
https://cran.r-project.org/web/packages/MatrixEQTL/
https://cran.r-project.org/web/packages/eqtl/
https://cran.r-project.org/web/packages/GeneticTools/
Fig. 7. Integrating NGS data for systems-level understanding. Knowledge integration resulting from analyzing sequencing data from genomics, epigenomics, transcriptomics, and
literature can help decode networks and variants underlying development and disease. A systems level study can yield better identiﬁcation of disease genes and drug targets.
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kernel density estimation model to describe the data (Boyle et al.,
2008; Buenrostro et al., 2013; Koohy et al., 2014). This model de-
termines regions with signiﬁcant levels of read overlap to deﬁne
peaks, and a bandwidth parameter is used to deﬁne the width of
peaks. Other common peak callers for deﬁning signiﬁcant sites in
open chromatin data are ZINBA and Hotspot (John et al., 2011;
Rashid et al., 2011). Peak detection methods are under continuous
development, and a variety of toolsmust be tested for obtaining the
best results.
5.4.2. Differential peak analyses
Differential regions (DR) are regions that have been found to be
signiﬁcantly different between data sets. The algorithms used to
detect these DR may vary signiﬁcantly, and may work on sharp,
broad, or both types of peak signals (e.g., MACS), and some may
consider biological replicates (e.g., DiffBind) (Steinhauser et al.,
2016). The number and size of DRs identiﬁed also varies signiﬁ-
cantly depending on the detection method (Table 6). Therefore, it is
important to select tools that aremore likely to be optimized for the
data set under scrutiny, and to validate signiﬁcant results experi-
mentally, if possible.
5.4.3. Identiﬁcation of enriched TF motif sequences
Identifying protein-DNA interactions is important for under-
standing gene regulatory mechanisms that drive cellular and or-
ganism level changes. DNA-binding proteins, such as TFs, often bindwith a bias for certain sequence motifs. DNA-binding motifs are
frequently represented via a position weight matrix (PWM) that
contains the log-likelihood of each base appearing at each position
of the motif as compared to a random background model (Stormo
et al., 1982). A wide range of TF binding motif identiﬁcation tools
exists (Table 6); these tools vary in their underlying mathematical
and computational methods (Tran and Huang, 2014). The use of
multiple algorithms in parallel to obtain recurring motifs using
ensemble methods has been recommended (Lihu and Holban,
2015). The identiﬁcation of sequence bias inherent to DNase I and
Tn5, for DNase-seq and ATAC-seq respectively, has also led to
development of novel algorithms which attempt to compensate for
these technical effects (Madrigal, 2015). Multiple well-annotated
databases of validated TF-binding motifs exist (Bryne et al., 2008;
Newburger and Bulyk, 2009; Wingender et al., 1996); some of
these databases also provide web-based platforms for motif min-
ing. These web tools search for candidate TF binding sites in data
produced from open chromatin assays, where each tool provides
customized parameters that can be chosen by the user.
5.5. Secondary analysis
In this section, we discuss additional computational approaches
for elucidating transcriptional regulatory mechanisms.
5.5.1. Elucidating TF-Mediated gene regulation
Genomewide TF binding sites (TFBS), as identiﬁed by peak
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with gene regulation. Location of TFBS may uncover regulatory
targets of TFs; e.g., if a peak is identiﬁed in close proximity of a
gene’s transcription start site (TSS), it is inferred as a putative target
gene; however, further experimental validation is required to
delineate biologically relevant interactions. TF ChIP-seq experi-
ments are reasonably accurate but target inference is restricted to a
single TF. In mammals, multiple TFs cooperatively (synergistically
or antagonistically) control gene expression (Chen et al., 2015);
hence, an array of TF ChIP-seq experiments is required to construct
combinatorial and higher order regulatory networks. Signiﬁcant
efforts have been made by ENCODE and high throughput ChIP-seq
projects to identify principles and dynamics of gene regulation
(Garber et al., 2012; Gerstein et al., 2012). Genomewide maps of
DNase I footprints and open chromatin regions identiﬁed by
DNase-seq or ATAC-seq experiments complement the ChIP-seq
data by providing active regulatory regions that can be interro-
gated for locations of TF binding motif sequences to uncover novel
TF interactions (Neph et al., 2012; Vierstra et al., 2014).
6. Systems integration
Cells in an organism contain numerous distinct small and large
molecules that work together for maintaining physiology and sur-
vival. NGS methods yield high quality data that measures the levels
or activity of some of these molecules at genome scale albeit
independently. Systems biology aims to elucidate normal and
abnormal functioning of the whole cell, tissue and the organism by
integrating multiple data sets (such as genetic, epigenetic, proteo-
mic, functional) on molecules into pathways and networks
(Barabasi et al., 2011; Chuang et al., 2010; Gustafsson et al., 2014;
Kitano, 2002; Vidal et al., 2011). In this section, we highlight two
speciﬁc systems frameworks that integrate NGS data sets to un-
cover gene regulatory networks and to identify variants that in-
ﬂuence expression levels of gene(s) (called expression quantitative
trait loci or eQTL). Table 7 lists available open source tools for
regulatory network inference and eQTL analysis.
Systems biology methods assist in nullifying issues caused by
false positives and false negatives obtained by analyzing single
“omics” data set (Ge et al., 2003). For example, not all DE genes
identiﬁed by the loss of NRL in photoreceptors are direct tran-
scriptional targets and integration of this data with NRL ChIP-seq
can reveal biologically relevant targets with high conﬁdence. Just
as methods to analyze NGS data sets are not completely optimized
and one can use different software, no benchmarking tools exist in
systems biology. We note that systems biology paradigms are
ﬂexible and that multiple data sets can be combined using different
parameters to answer a speciﬁc query (Fig. 7).
6.1. Regulatory network inference
Precise control of gene regulation is central to biological pro-
cesses and is modulated by complex yet highly organized and in-
tegrated networks that may span multiple levels (Thompson et al.,
2015). Binding of TFs to DNA elements and chromatin re-
organization factors including those associated with DNA methyl-
ation and histone modiﬁcations can stabilize transcription initia-
tion complex at the promoter region and are largely responsible for
controlling gene expression patterns. NGS-based transcriptome
proﬁling provides quantiﬁed gene expression levels, which can be
integrated with other molecular proﬁles (such as DNA methylome
or histone methylation and acetylation) to initiate the construction
of genome scale gene regulatory networks (GRNs) underlying
development and disease (Yang et al., 2015). Inference of GRN using
a single genomewide data set would likely yield physicalassociation networks in which many regulatory interactions may
not be functionally relevant (Marbach et al., 2012b). Such networks
especially those inferred from the expression data would likely
contain large number of false positives (Ge et al., 2003). Integration
of different NGS datasets is thus desired to infer a functional reg-
ulatory network, which is still a major challenge especially for
mammalian systems. Computational and mathematical methods
are begun to emerge lately to systematically integrate high-
throughput data sets for elucidating GRNs. For example, BETA
(Binding and expression target analysis) combines ChIP-seq and
RNA-seq data to elucidate gene regulation (Wang et al., 2013). BETA
also conducts network motif analysis to identify putative collabo-
rating factors that contribute to gene expression.
NGS data can be integrated for systems studies at the tran-
scriptional and post-transcriptional levels to infer genetic in-
teractions, such as those between genes/transcripts and miRNAs
(Cheng et al., 2011). A comprehensive systems integration approach
to reverse engineer networks has been formulated in a machine-
learning framework that uses both supervised and unsupervised
methods to predict regulatory edges by integrating RNA-seq, TF
ChIP-seq and histone modiﬁcation data sets along with prior
knowledge of conserved motifs of TF as input features (Marbach
et al., 2012b). A rank combined framework that assimilates data
from NGS and other high throughput technologies (such as
microarray or ChIP-chip) has been successfully implemented to
discover novel central regulators that participate in modulating
cellular plasticity in Th17 cells (Ciofani et al., 2012). This method
ranks regulatory interactions based on multiple metrics including
correlation and TF binding scores obtained from RNA-seq and
microarray experiments, and DE scores computed from wild type
and knockout experiments.
6.2. eQTL
Every human being carries millions of genetic variants in the
genome (Genomes Project et al., 2015; Sudmant et al., 2015). While
a majority of these variants may be benign, many can potentially
impact cell/tissue speciﬁc gene expression patterns (Consortium,
2015) that would in turn affect downstream traits ranging from
morphological and functional diversity to disease and response to
treatments (Albert and Kruglyak, 2015; Cookson et al., 2009). eQTL
refers to a genomic region, which harbors sequence/structural
variants that inﬂuence gene expression levels; these regulatory
variants can be identiﬁed by combining global expression proﬁles
from cells/tissues and under different conditions with genomewide
genetic variations (Gilad et al., 2008). NGS methods can permit
more precise quantiﬁcation of eQTL variations across cell types or
tissues and discern their regulatory impact on gene expression
(Bahcall, 2015; Majewski and Pastinen, 2011). Regulatory variations
that map in close proximity to the target gene(s) in the genome are
classiﬁed as cis-eQTLs and those mapping far away (even on a
different chromosome) are called trans-eQTLs.
The concept of eQTLs is extremely attractive because it allows us
to correlate genetic diversity to phenotypic manifestations. Inmany
inherited retinal diseases, the presence of a genetic variation is not
always associated with identical clinical phenotypes and other
genomic variants are predicted to modify the impact of causal
mutation; e.g., the presence of a common RPGRIP1L variant (A229T)
can lead to highly penetrant retinal degeneration phenotype in
ciliopathies (Khanna et al., 2009). However, in case of common
multifactorial diseases the causality is difﬁcult to establish, and
GWAS of complex traits have discovered a vast majority of genetic
susceptibility variants that have relatively small impact on the
disease risk. Most GWAS-identiﬁed disease associated variants are
localized in gene deserts or non-coding genome regions
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through modulation of gene expression (i.e., eQTL). Functional
implications of a disease-associated eQTL should however be
evaluated in the context of cells/tissues that are inﬂuenced by the
disease. For example, genetic studies have discovered 45 inde-
pendent common variants associated with AMD (Fritsche et al.,
2016), and it is prudent to look at their impact on gene expres-
sion in the retina, retinal pigment epithelium or choroid. GTEx
project was initiated with a goal to create the resource for sys-
tematic study of genetic variations in multiple reference human
tissues (Consortium, 2015). GTEx consortium, however, does not
include ocular cells/tissues. Our laboratory has therefore under-
taken this task by generating RNA-seq data and genotypes for over
400 human retina samples.
7. Concluding remarks
Precision medicine is designed to provide targeted therapies to
patients based on their individual genetic architecture and disease.
Though the current use of precision medicine in clinical settings is
limited, substantial efforts, such as the PrecisionMedicine Initiative
(www.nih.gov/precision-medicine-initiative-cohort-program), are
underway to facilitate a more rapid progression of the ﬁeld. NGS
methodologies have allowed the collection of valuable genomic
information from individuals, thereby accelerating patient-
oriented decision-making including assessment of disease risk
and/or prediction of drug response. Systems biology approaches,
such as network modeling of genetic variants, are expected to un-
cover and expedite better understanding of disease causality and
enable the design of customized treatments based on an in-
dividual’s genetic and epigenetic proﬁle.
In this review, we have primarily focused on genome, tran-
scriptome and epigenome analysis with a goal to provide a
comprehensive perspective of NGS methods and tools to scientists
in the vision ﬁeld. WES and targeted sequencing are becoming
standard methodology for identifying genetic variants/mutations
in retinal research and clinical diagnosis. NGS-based methods are
increasingly being used to evaluate drug targets and small mole-
cules and their broader impact on retinal cell/tissue function (Chen
and Palczewski, 2016; Kaewkhaw et al., 2016). Over 240 genes have
so far been associated with retinal diseases; however, underlying
pathways leading to disease pathology are poorly understood. A
vast majority of functional studies have focused on one or few
genes, which provide useful though limited insight into molecular
and cellular pathways. Genes and their products (such as proteins,
miRNA) are part of combinatorial functional networks, and any
genetic (sequence variation/mutation) or epigenetic change can
potentially have an impact on multiple physiological processes
leading to cellular/organismic adaptation or disease (Yang et al.,
2015). It is therefore imperative that we elucidate global proﬁles
of transcriptome and epigenome, together with those of lncRNA,
miRNA and other noncoding transcribed sequences, under normal
(control) and abnormal (disease) conditions focusing on different
cell types in the retina/eye and generate gene interaction networks.
While a majority of reported NGS data in retina/eye originates from
small number of samples and whole tissues (Farkas et al., 2013;
Tian et al., 2015), several groups have initiated NGS studies on
speciﬁc cell types (Macosko et al., 2015; Mo et al., 2016; Siegert
et al., 2012) (Kim et al., 2016). An array of NGS data thus provides
unprecedented opportunities to address fundamental questions
related to gene/genome organization, function and regulation,
which in turn would dramatically inﬂuence our understanding of
cell physiology and pathogenic mechanisms. A higher-order inte-
grative analysis of different data sets would permit extraction of
useful pathway and network information at systems level. We havebrieﬂy touched upon two such aspects and discussed strategies for
elucidating regulatory networks and delineating causality of vari-
ants in complex diseases.
The rapidly changing and ever evolving NGS ﬁeld is now leading
to applications where one can examine genomic, transcriptomic,
and epigenomic landscape even at the level of an individual cell;
such studies are expected to have a broad impact on biology and
medicine (Wang and Navin, 2015). Single-cell RNA-seq has accel-
erated molecular proﬁling of rare cell populations in complex tis-
sues. Drop-seq, a massively parallel transcriptome analysis
approach, has been successfully applied to the mouse retina,
leading to the identiﬁcation of 39 distinct cell populations repre-
senting speciﬁc subtypes of one of the seven major retinal cells
(Macosko et al., 2015). Additionally, NGS-based epigenome tech-
nologies have adapted to solve speciﬁc questions on the translation
of genotype information into phenotype; these include ChIP-exo
(Rhee and Pugh, 2012) that can detect TF binding sites at the sin-
gle nucleotide resolution, and FAIRE-seq (Bianco et al., 2015; Giresi
and Lieb, 2009) that identiﬁes open chromatin regions in ﬁxed
nuclei. Both ATAC-seq and ChIPmentation (Schmidl et al., 2015)
take advantage of the ﬂexibility and efﬁciency provided by the use
of the Tn5 transposase in library preparation in order to assay open
chromatin and protein binding, respectively. NGS assays must
continue to adapt to the increasing demand for rapid, accurate, and
cost-effective generation of epigenomewide analysis.
NGS based approaches are rapidly gaining broad applicability.
However, current computational methods are not able to harness
the full potential of large genomic and epigenomic data sets being
generated by innovations in NGS technology. Thus, a greater focus
is needed on developing novel tools for integrated systems level
analysis. Machine learning including neural networks and support
vector machines and other mathematical models are being built to
integrate knowledge from NGS data generated at diverse molecular
levels, but systems integration models are yet to be standardized.
The pace of data production has added a new dimension of chal-
lenges to computational and systems biologists; thus, additional
innovations are needed for extracting useful information to have a
desired impact of NGS in solving challenges of biology and
medicine.
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